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Abstract	  
	   Invariant	  natural	  killer	  T-­‐cells	  (iNKT)	  are	  a	  subset	  of	  unconventional	  T-­‐cells	  arising	  
from	  the	  same	  pool	  of	  CD4+8+	  double-­‐positive	  (DP)	  precursors	  as	  conventional	  T-­‐cells,	  but	  
are	  distinct	  in	  their	  T-­‐cell	  receptor	  (TCR)	  specificity	  -­‐	  recognizing	  CD1d-­‐bound	  glycolipids	  -­‐	  as	  
well	  as	  constitutive	  expression	  of	  memory	  cell	  markers	  and	  cytokine	  mRNA.	  Development	  of	  
iNKT	  within	  the	  thymus	  is	  drastically	  different	  in	  terms	  of	  both	  the	  molecular	  requirements,	  
and	  the	  transcriptional	  processes	  involved.	  However,	  like	  conventional	  thymocytes,	  they	  are	  
known	  to	  undergo	  positive	  and	  negative	  selective	  processes	  to	  screen	  TCR	  functionality	  and	  
auto-­‐reactivity,	  albeit	  on	  contrasting	  cell	  types	  –	  DP	  thymocytes	  and	  dendritic	  cells	  
respectively.	  Progressive	  maturational	  stages	  are	  defined	  by	  expression	  of	  activation	  and	  NK-­‐
cell	  markers.	  Conventional	  thymocytes	  up-­‐regulate	  the	  chemokine	  receptors	  CCR4	  and	  CCR7	  
post-­‐positive	  selection,	  which	  control	  re-­‐localization	  to	  the	  medulla,	  where	  they	  are	  
negatively	  selected	  on	  self-­‐antigens	  promiscuously	  expressed	  by	  medullary	  epithelial	  cells.	  
On	  deletion	  of	  these	  chemokine	  receptors,	  development	  is	  unaffected,	  but	  auto-­‐reactive	  T-­‐
cells	  escape	  deletion,	  and	  cause	  auto-­‐immunity	  in	  the	  periphery.	  Our	  work	  has	  
demonstrated	  that	  deletion	  of	  either	  receptor	  severely	  impedes	  thymic	  generation	  of	  iNKT,	  
although	  only	  CCR4	  is	  expressed	  on	  developing	  iNKT,	  suggesting	  localization	  of	  other	  CCR7+	  
cell	  types	  with	  iNKT	  is	  vital	  to	  their	  development.	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Section	  2.0:	  Introduction	  
2.1:	  Efficient	  positive	  and	  negative	  selection	  are	  reliant	  on	  chemokine	  receptor	  signaling	  
	   The	  thymus	  is	  a	  primary	  lymphoid	  organ	  acting	  as	  the	  site	  of	  T-­‐cell	  development	  and	  
maturation,	  and	  is	  divided	  into	  two	  functional	  sub-­‐compartments,	  the	  cortex	  and	  medulla,	  
each	  of	  which	  is	  occupied	  by	  a	  unique	  population	  of	  thymic	  epithelial	  cells	  (TECs)1,2.	  Bone	  
marrow	  derived	  precursors	  enter	  at	  the	  cortico-­‐medullary	  junction,	  and	  traffic	  into	  the	  
subcapsular	  region	  of	  the	  cortex	  in	  response	  to	  signaling	  through	  chemokine	  receptors	  CCR9	  
and	  CXCR43.	  During	  this	  time,	  they	  undergo	  T	  cell	  receptor	  (TCR)	  gene	  rearrangements	  to	  
form	  a	  clonally	  unique	  TCR4,	  capable	  of	  binding	  a	  specific	  peptide	  antigen	  bound	  in	  a	  surface	  
expressed	  major	  histocompatibility	  complex	  (MHC)	  molecule.	  Thymocytes	  also	  up-­‐regulate	  
the	  co-­‐receptors	  CD4	  and	  CD8	  to	  become	  double	  positive	  (DP)	  cells5.	  At	  this	  stage,	  cells	  are	  
selected	  to	  progress	  dependent	  on	  their	  successful	  formation	  of	  a	  TCR	  capable	  of	  binding	  
MHC	  on	  the	  surface	  of	  cortical	  thymic	  epithelial	  cells	  (cTEC)6.	  Ligation	  provides	  thymocytes	  
with	  essential	  survival	  signals	  in	  a	  process	  known	  as	  positive	  selection,	  and	  cells	  down-­‐
regulate	  either	  CD4	  or	  CD8	  (depending	  on	  the	  class	  of	  MHC	  bound)7	  to	  become	  single	  
positive	  (SP	  cells),	  and	  concomitantly	  express	  high	  levels	  of	  CCR4	  and	  CCR78.	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   CCR4	  and	  CCR7	  control	  trafficking	  of	  SP	  thymocytes	  into	  the	  thymic	  medulla,	  wherein	  
they	  undergo	  another	  selective	  process	  –	  negative	  selection	  –	  in	  which	  they	  are	  screened	  for	  
TCR	  auto-­‐reactivity	  by	  medullary	  TEC	  (mTEC)	  and	  dendritic	  cells	  (DCs),	  and	  induced	  to	  
apoptose	  on	  strong	  TCR-­‐ligation	  by	  auto-­‐antigen5.	  mTEC	  are	  capable	  of	  promiscuously	  
expressing	  tissue-­‐specific	  antigens	  (TSAs)	  for	  this	  purpose,	  partially	  under	  the	  control	  of	  the	  
autoimmune	  regulator	  gene	  (Aire)	  in	  mature	  CD80hi	  mTECs9.	  These	  antigens	  can	  also	  be	  
acquired	  for	  presentation	  by	  DCs10.	  The	  ligands	  for	  CCR4	  (CCL5,	  CCL17,	  CCL22)	  and	  CCR7	  
(CCL19,	  CCL21)	  are	  also	  expressed	  by	  mTEC	  in	  a	  partially	  Aire-­‐dependent	  manner11,	  although	  
reduction	  in	  the	  Aire-­‐/-­‐	  thymus	  may	  in	  part	  be	  indirect,	  as	  mTEC	  expressing	  CCR7	  ligands	  have	  
recently	  been	  identified	  as	  a	  separate	  population	  to	  those	  expressing	  Aire11,12.	  Auto-­‐
immunity,	  as	  characterized	  by	  tissue-­‐specific	  lymphocytic	  infiltrations,	  has	  been	  observed	  
not	  only	  in	  mice	  where	  Aire	  has	  been	  deleted11,	  but	  also	  CCR7-­‐/-­‐	  mice13,14;	  thymocyte	  
development	  proceeds	  normally	  in	  both,	  but	  is	  largely	  restricted	  to	  the	  cortex11,14	  (more	  
notably	  in	  the	  CCR7-­‐/-­‐),	  allowing	  thymocytes	  with	  TSA-­‐reactive	  TCRs	  to	  escape	  negative	  
selection.	  Aire-­‐/-­‐	  and	  CCR7-­‐/-­‐	  thymi	  also	  display	  defective	  medullary	  development	  –	  mature	  
CD80hi	  mTEC	  largely	  fail	  to	  develop	  in	  the	  Aire-­‐/-­‐11,	  and	  medullary	  architecture	  is	  altered	  in	  
the	  CCR7-­‐/-­‐,	  producing	  small,	  non-­‐continuous	  pockets	  of	  mTEC14.	  This	  is	  likely	  due	  to	  the	  
reliance	  of	  mTEC	  maturation	  on	  provision	  of	  CD40-­‐CD40L	  interactions	  by	  SP	  thymocytes2.	  
	  
2.2:	  Selection	  and	  development	  of	  iNKT	  in	  the	  thymus	  and	  periphery	  
	   Thymic	  selective	  processes	  are	  also	  imposed	  on	  invariant	  natural	  killer	  T-­‐cells	  (iNKT).	  
iNKT	  are	  an	  unconventional	  T-­‐cell	  subset	  notable	  for	  their	  constitutive	  expression	  of	  memory	  
and	  NK-­‐cell	  markers15,	  as	  well	  as	  cytokine	  mRNA,	  allowing	  rapid	  production	  and	  export	  of	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cytokines	  upon	  activation16.	  This	  capacity	  allows	  iNKT	  to	  play	  dominant	  roles	  in	  both	  
tolerance	  and	  immunity	  -­‐	  they	  have	  been	  implicated	  in	  tumour	  immunity17,18,	  transplant	  
rejection19	  and	  asthma	  development20,	  and	  their	  absence	  or	  malfunction	  has	  been	  
implicated	  in	  several	  autoimmune	  diseases21.	  	  
	   iNKT	  are	  derived	  from	  the	  pool	  of	  DP	  cells	  within	  the	  thymus22,	  and	  are	  
phenotypically	  indistinguishable	  from	  conventional	  DP	  thymocytes,	  except	  by	  TCR	  
specificity.	  The	  iNKT	  TCR	  is	  produced	  at	  a	  low	  frequency	  (~1:106)	  from	  the	  random	  gene	  
recombination	  events	  defining	  production	  of	  novel	  TCRs	  in	  early	  thymocyte	  development23.	  
It	  is	  distinguishable	  from	  those	  of	  conventional	  T-­‐cells	  as	  it	  binds	  the	  non-­‐classical	  MHC	  
molecule	  CD1d24,	  which	  displays	  glycolipid,	  rather	  than	  peptide,	  antigens.	  The	  assembly	  of	  
the	  iNKT	  TCR	  requires	  recombination	  of	  Vα14-­‐Jα18,	  which	  is	  paired	  with	  Vβ8.2,	  Vβ7.2	  or	  
Vβ7.1,	  and	  hence	  is	  often	  referred	  to	  as	  semi-­‐invariant23.	  Due	  to	  it’s	  positioning,	  Jα18	  
recombination	  occurs	  late	  in	  DP	  development,	  which	  contributes	  to	  both	  the	  rarity	  of	  iNKT	  
among	  developing	  thymocytes,	  as	  well	  as	  the	  susceptibility	  of	  iNKT	  development	  to	  deletion	  
of	  factors	  which	  extend	  the	  life-­‐span	  of	  DP	  cells25.	  iNKT	  hence	  require	  the	  E-­‐protein	  HEB25,	  
and	  transcription	  factors	  RORgt26,27,28	  and	  c-­‐Myb29,	  which	  together	  contribute	  to	  expression	  
of	  the	  anti-­‐apoptotic	  molecule	  Bcl-­‐XL23.	  
	   Upon	  TCR	  assembly,	  iNKT	  undergo	  positive	  selection	  within	  the	  cortex30,	  as	  
demonstrated	  by	  the	  complete	  absence	  of	  iNKT	  in	  CD1d-­‐/-­‐	  mice21,	  and	  low	  affinity	  bias	  of	  the	  
iNKT	  TCR	  upon	  transgenic	  overexpression	  of	  CD1d31,32,	  wherein	  iNKT	  are	  reduced.	  Through	  
studies	  involving	  deletion	  and	  transgenic	  expression	  of	  CD1d,	  this	  process	  was	  found	  to	  
occur	  upon	  interaction	  with	  DP	  thymocytes,	  as	  iNKT	  selection	  proceeded	  normally	  when	  
CD1d	  expression	  was	  driven	  by	  the	  promoter	  for	  the	  Lck	  gene33,	  expression	  of	  which	  is	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restricted	  to	  DPs.	  Negative	  selection	  of	  iNKT	  also	  occurs,	  mediated	  by	  DCs,	  and	  mice	  
expressing	  GFP	  as	  a	  reporter	  for	  the	  TCR-­‐signaling	  downstream	  element	  Nur77	  show	  that	  
iNKT	  TCRs	  possess	  greater	  self-­‐reactivity	  than	  those	  of	  conventional	  T-­‐cells34,	  although	  the	  
identity	  of	  selective	  antigens	  has	  yet	  to	  be	  fully	  elucidated.	  Similarly,	  deletion	  of	  DGKα	  or	  
DGKζ	  –	  proteins	  inhibitory	  of	  TCR	  signaling	  –	  also	  triggers	  enhanced	  deletion	  of	  iNKT	  after	  
normal	  positive	  selection35,	  suggesting	  tight	  regulation	  of	  TCR	  signaling	  strength	  is	  of	  
particular	  importance.	  Recent	  evidence	  suggests	  that	  the	  glycolipid	  antigen	  iGb3	  contributes	  
to	  positive	  selection36,	  as	  well	  as	  β-­‐GlcCer37,	  as	  siRNA	  silencing	  of	  enzymes	  involved	  synthesis	  
of	  the	  latter	  limits	  iNKT	  production.	  However,	  as	  some	  enzymes	  may	  be	  required	  in	  synthesis	  
of	  multiple	  glycolipids,	  iNKT	  develop	  normally	  without	  iGb3,	  it	  is	  likely	  that	  other	  important	  
selective	  antigens	  have	  yet	  to	  be	  identified36.	  Currently	  the	  exogenous	  antigen	  α-­‐
galactosylceramide	  (α-­‐GalCer),	  which	  derives	  from	  a	  marine	  sponge,	  is	  used	  for	  both	  
identification	  and	  activation	  of	  iNKT38.	  
	   Positive	  selection	  of	  another	  unconventional	  T-­‐cell	  subset,	  namely	  regulatory	  T-­‐cells,	  
is	  known	  to	  be	  heavily	  dependent	  receipt	  of	  co-­‐stimulatory	  signals	  on	  TCR	  ligation39.	  This	  is	  
similarly	  true	  of	  iNKT,	  which	  require	  the	  homotypic	  interactions	  of	  SLAM	  family	  members	  
(namely	  SLAM	  and	  Ly108),	  for	  selection40.	  SLAM	  signaling	  is	  transduced	  into	  the	  cell	  via	  the	  
SLAM	  adapter	  protein	  (SAP),	  which	  in	  turn	  activates	  Fyn	  kinase,	  although	  other	  mediators	  
are	  likely	  involved,	  as	  the	  phenotypic	  loss	  of	  iNKT	  upon	  deletion	  is	  much	  greater	  in	  in	  the	  
SAP-­‐/-­‐	  than	  Fyn-­‐/-­‐	  41.	  Signals	  provided	  during	  positive	  selection	  initiate	  a	  series	  of	  defined	  
maturational	  stages	  specific	  to	  iNKT	  development,	  and	  defined	  by	  the	  expression	  of	  CD24,	  
CD44	  and	  NK1.1.	  iNKT	  uniformly	  down-­‐regulate	  CD8	  to	  become	  CD4	  SP	  immediately	  after	  
negative	  selection,	  and	  cells	  are	  identifiable	  immediately	  post-­‐selection	  (stage	  0)	  by	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expression	  of	  CD2442	  -­‐	  equivalent	  to	  CD69+	  conventional	  thymocytes43.	  HSA	  is	  then	  itself	  
down-­‐regulated	  (stage	  1),	  and	  iNKT	  progressively	  up-­‐regulate	  CD44	  (CD44+NK1.1-­‐,	  stage	  2),	  
before	  acquiring	  expression	  of	  the	  NK-­‐cell	  marker	  NK1.1	  (CD44+NK1.1+,	  stage	  3)31.	  The	  
majority	  of	  CD44+NK1.1+	  iNKT	  in	  the	  thymus	  represent	  a	  mature	  resident	  population,	  
retained	  in	  response	  to	  expression	  of	  CXCR344.	  
	   Development	  of	  iNKT	  can	  either	  be	  entirely	  confined	  to	  the	  thymus,	  or	  cells	  can	  exit	  
to	  the	  periphery	  at	  stage	  2,	  and	  progress	  to	  express	  NK1.1,	  although	  many	  peripheral	  iNKT	  
remain	  NK1.1-­‐,	  and	  are	  functionally	  mature45.	  In	  either	  case,	  development	  is	  controlled	  by	  
several	  transcription	  factors	  known	  to	  be	  integral	  to	  the	  development	  and	  function	  of	  other	  
conventional	  and	  unconventional	  T-­‐cell	  subsets,	  as	  well	  as	  external	  signaling	  by	  cytokines	  
and	  co-­‐stimulatory	  molecules31.	  Expression	  of	  the	  transcription	  factor	  promyelocytic	  
leukemia	  zinc-­‐finger	  protein	  (PLZF)	  in	  cells	  of	  haematopoietic	  lineage	  is	  largely	  restricted	  to	  
iNKT,	  mucosal-­‐associated	  innate	  lymphoid	  cells	  and	  some	  Υδ	  T-­‐cells31,46.	  High	  levels	  of	  
expression	  are	  induced	  by	  a	  combination	  of	  TCR	  and	  Ly108	  signaling	  in	  all	  iNKT	  post-­‐positive	  
selection15,40.	  iNKT	  are	  greatly	  depleted	  upon	  deletion	  of	  PLZF	  –	  PLZF-­‐/-­‐	  iNKT	  show	  defective	  
trafficking	  and	  cytokine	  production,	  stall	  at	  stage	  0,	  and	  fail	  to	  down-­‐regulate	  CD4	  (normally	  
lost	  by	  ~50%	  of	  iNKT	  in	  the	  wildtype)15.	  Conventional	  T-­‐cells	  acquire	  memory	  markers	  and	  
can	  produce	  IL-­‐17	  upon	  transduction	  of	  constitutively	  expressed	  PLZF47.	  PLZF	  is	  highly	  
expressed	  in	  all	  thymic	  iNKT	  at	  stages	  0-­‐2,	  but	  undergoes	  T-­‐bet	  mediated	  down-­‐regulation	  
when	  cells	  reach	  full	  maturity	  –	  all	  peripheral	  iNKT	  are	  PLZFlow	  15.	  
	   iNKT	  rely	  on	  two	  Tec	  kinases	  (Itk	  and	  Rlk)25,	  as	  well	  as	  signaling	  through	  the	  Vitamin-­‐
D	  receptor48,	  to	  initiate	  expression	  of	  the	  transcription	  factor	  T-­‐bet49,	  which	  is	  commonly	  
associated	  with	  type	  1	  helper	  T-­‐cells,	  but	  essential	  in	  proper	  iNKT	  development.	  Expression	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of	  T-­‐bet	  is	  initiated	  by	  co-­‐stimulation	  through	  ICOS	  and	  CD2850,	  the	  latter	  being	  required	  on	  
both	  iNKT	  and	  conventional	  T-­‐cells	  for	  intra-­‐thymic	  proliferation	  of	  iNKT42.	  It	  is	  well	  
established	  that	  iNKT	  undergo	  a	  period	  of	  intense	  proliferation	  in	  response	  to	  IL-­‐15	  early	  in	  
their	  development	  during	  CD44	  up-­‐regulation51.	  Multiple	  transcription	  factors,	  including	  the	  
cell-­‐cycle	  regulator	  c-­‐Myc52,	  and	  NFκB	  family	  member	  RelA53,	  are	  indispensible	  in	  this	  early	  
proliferative	  burst,	  and	  iNKT	  are	  greatly	  reduced	  on	  their	  deletion52,53.	  Nuclear	  relocation	  of	  
RelA	  through	  the	  classical	  NFκB	  pathway	  has	  been	  demonstrated	  to	  be	  of	  importance	  in	  
inducing	  expression	  of	  the	  IL-­‐receptor	  common	  γ-­‐chain	  (γC),	  which	  sensitizes	  CD44low	  iNKT	  to	  
IL-­‐15-­‐	  and,	  less	  significantly,	  IL-­‐7-­‐mediated	  proliferative	  responses	  in	  vitro53.	  IL-­‐15	  is	  trans-­‐
presented	  by	  high-­‐affinity	  receptors	  on	  the	  surface	  of	  mTEC	  -­‐	  where	  it	  drives	  extensive	  
proliferation	  of	  early	  iNKT54.	  IL-­‐15	  expression	  by	  mTEC,	  as	  well	  as	  peripheral	  DCs	  and	  stromal	  
cells,	  is	  also	  required	  for	  homeostasis	  of	  iNKT	  within	  the	  thymus	  (mature	  NK1.1+	  iNKT)	  and	  
liver	  (all	  CD44hi	  iNKT)	  respectively,	  but	  not	  the	  spleen,	  where	  it’s	  absence	  is	  likely	  
compensated	  by	  other	  factors36.	  Another	  cytokine	  –	  TGFβ	  -­‐	  is	  not	  required	  for	  thymic	  
development	  of	  conventional	  T-­‐cells,	  but	  is	  known	  to	  play	  a	  role	  in	  several	  developmental	  
processes	  in	  iNKT;	  it	  drives	  early	  expansion	  and	  survival,	  and	  maintains	  expression	  of	  T-­‐bet	  /	  
CD122	  in	  mature	  cells,	  enabling	  passage	  to	  the	  NK1.1+	  stage31.	  
	  
2.3:	  Extra-­‐thymic	  maturation,	  and	  unique	  sub-­‐populations	  
	   Although	  we	  have	  long	  been	  aware	  of	  the	  presence	  of	  phenotypically	  distinct	  
populations	  of	  iNKT	  in	  terms	  of	  surface	  maker	  (NK1.1	  and	  CD4)	  and	  cytokine	  expression,	  
these	  have	  been	  usefully	  characterized	  to	  a	  greater	  extent	  in	  a	  recent	  paper	  by	  Watarai	  et	  
al16.	  Thymic	  iNKT	  were	  divided	  on	  the	  basis	  of	  expression	  of	  IL-­‐17RB	  (the	  IL-­‐25	  receptor)	  and	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CD4,	  and	  unique	  homeostatic	  requirements	  and	  cytokine	  profiles	  were	  observed	  in	  IL-­‐17RB-­‐
CD4+/-­‐,	  IL-­‐17RB+CD4+	  and	  IL-­‐17RB+CD4-­‐	  iNKT16.	  IL-­‐17RB-­‐	  cells	  were	  entirely	  NK1.1+	  (whereas	  
IL-­‐17RB+	  are	  largely	  NK1.1-­‐)	  and	  the	  only	  population	  to	  express	  CD122,	  signifying	  their	  
requirement	  for	  IL-­‐15	  in	  homeostasis16.	  Conversely	  IL-­‐17RB+	  iNKT	  were	  normal	  in	  IL-­‐15-­‐/-­‐	  
mice16.	  Upon	  activation,	  IL-­‐17RB-­‐	  cells	  produced	  IFNγ	  in	  response	  to	  IL-­‐1216.	  IL-­‐17RB+CD4+	  
iNKT	  seemed	  to	  represent	  a	  significant	  portion	  of	  CD44low	  (stage	  0-­‐1)	  cells	  -­‐	  although	  many	  
were	  also	  CD44+NK1.1-­‐	  (stage	  2)	  –	  and	  required	  IL-­‐25	  to	  produce	  an	  array	  of	  Th2	  (IL-­‐4,	  IL-­‐13),	  
Th17	  (IL-­‐17,	  IL-­‐22)	  and	  Th9	  (IL-­‐9,	  IL-­‐10)	  cytokines16,56.	  The	  immature	  phenotype	  of	  these	  cells	  
is	  unsurprising	  given	  that	  all	  iNKT	  are	  known	  to	  express	  CD4	  immediately	  post-­‐selection27.	  
Finally,	  IL-­‐17RB+CD4-­‐	  iNKT	  were	  the	  previously	  identified	  subset	  expressing	  RORgt,	  which	  
produce	  IL-­‐17,	  requiring	  IL-­‐23	  signaling16,27,28.	  
	   This	  paper	  also	  went	  on	  to	  establish	  that,	  although	  immature	  (stage	  1-­‐2)	  iNKT	  were	  
largely	  IL-­‐17RB+,	  some	  IL-­‐17RB-­‐	  cells	  were	  present16.	  These	  appeared	  to	  represent	  a	  distinct	  
subset	  of	  precursors,	  as	  stage	  1-­‐2	  IL-­‐17RB+	  cells	  sorted	  into	  fetal	  thymic	  organ	  cultures	  
ablated	  of	  haematopoietic	  cells	  failed	  to	  form	  mature	  IL-­‐17RB-­‐	  iNKT,	  and	  vice	  versa16.	  It	  is	  
currently	  unclear	  at	  which	  early	  stage,	  and	  under	  what	  conditions	  these	  phenotypically	  
distinct	  iNKT	  subsets	  initially	  diverge.	  CD4-­‐reporter	  mice	  have	  shown	  that	  all	  CD4-­‐	  iNKT	  
originate	  from	  CD4+	  precursors27,	  but	  not	  whether	  these	  precursors	  are	  common	  to	  CD4+/-­‐	  
cells,	  or	  if	  cells	  are	  differentially	  imprinted	  from	  the	  DP	  stage.	  It	  has	  recently	  been	  
determined	  that	  TGFβ	  signaling,	  although	  a	  requirement	  in	  the	  development	  of	  all	  iNKT	  sub-­‐
populations,	  acts	  via	  different	  pathways	  to	  promote	  development.	  RORgt+	  iNKT	  from	  the	  IL-­‐
17RB+CD4-­‐	  subset	  are	  promoted	  to	  survive	  through	  a	  SMAD4-­‐dependent	  pathway,	  and	  
require	  TGFβ	  for	  peripheral	  homeostasis,	  whereas	  for	  RORgt-­‐	  iNKT	  development	  occurs	  
	   12	  
independent	  of	  SMAD4,	  and	  survival	  requires	  IL-­‐15	  signaling27.	  It	  however	  remains	  unclear	  
whether	  these	  findings	  on	  SMAD4	  independence	  hold	  true	  if	  RORgt-­‐	  populations	  are	  divided	  
based	  on	  IL-­‐17RB	  expression.	  
	   Another	  recent	  paper	  used	  in	  situ	  thymocyte	  labeling	  to	  distinguish	  recent	  thymic	  
emigrant	  (RTE)	  iNKT	  (which	  were	  Neuropilin-­‐1+)	  in	  the	  spleen	  and	  peripheral	  lymph	  nodes	  
(LNs),	  and	  determined	  not	  only	  that	  these	  largely	  consist	  of	  IL-­‐4-­‐	  and	  IL-­‐17-­‐producing	  cells,	  
but	  that	  the	  majority	  of	  peripheral	  IL-­‐17+	  cells	  were	  in	  fact	  RTE45.	  Although	  these	  cells	  were	  
not	  phenotyped	  on	  the	  basis	  of	  surface	  marker	  expression,	  this	  suggests	  that	  mature	  NK1.1+	  
iNKT	  are	  minimal	  among	  those	  cells	  exported	  from	  the	  thymus,	  and	  require	  additional	  
maturation	  steps	  to	  acquire	  cytokine	  expression,	  whereas	  NK1.1-­‐	  cells	  are	  largely	  
functionally	  mature45.	  That	  IL-­‐17+	  cells	  were	  all	  Neuropilin-­‐1+	  in	  the	  spleen	  does	  not	  
necessarily	  confirm	  that	  these	  cells	  are	  short-­‐lived	  –	  it	  is	  also	  possible	  that	  RORgt+	  cells	  
either	  change	  cytokine	  expression	  over	  time,	  or	  instead	  relocate.	  In	  fact,	  tissue	  distribution	  
of	  iNKT	  subtypes	  is	  quite	  varied16,	  likely	  reflecting	  the	  availability	  of	  specific	  factors	  for	  
homeostasis,	  as	  well	  as	  imprinted	  homing	  markers.	  	  
	   IL-­‐17RB+CD4+/-­‐	  iNKT	  are	  in	  fact	  greatly	  enriched	  in	  the	  lung20	  in	  addition	  to	  the	  tissue	  
draining	  LNs16,	  largely	  as	  a	  result	  of	  expression	  of	  CCR420,56	  (although	  CCR7	  is	  also	  co-­‐
expressed).	  CCR4	  is	  detected	  on	  these	  populations,	  but	  not	  IL-­‐17RB-­‐	  iNKT,	  from	  generation	  in	  
the	  thymus16.	  Airway	  hyper-­‐responsivity	  (AHR),	  an	  autoimmune	  model	  of	  asthma,	  can	  be	  
induced	  in	  mice	  through	  intra-­‐nasal	  admission	  of	  α-­‐GalCer	  as	  a	  result	  of	  IL-­‐23-­‐dependent	  
cytokine	  production	  by	  iNKT56,57,	  but	  is	  abrogated	  when	  mice	  are	  pre-­‐treated	  with	  anti-­‐
CCL17/22	  antibodies20.	  This	  effect	  is	  replicated	  when	  wildtype	  mice	  are	  reconstituted	  with	  
CCR4-­‐/-­‐	  bone	  marrow20,	  suggesting	  that	  chemokine	  receptor	  homing	  of	  iNKT	  to	  the	  lungs	  is	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an	  absolute	  requirement	  of	  AHR	  development.	  However,	  to	  our	  knowledge,	  no	  study	  has	  as	  
yet	  analyzed	  the	  importance	  of	  iNKT	  chemokine	  receptor	  expression	  in	  the	  context	  of	  intra-­‐
thymic	  development.	  This	  issue	  is	  particularly	  interesting	  knowing	  that	  iNKT	  are	  lost	  in	  mice	  
with	  disrupted	  medullary	  development	  –	  this	  is	  true	  of	  both	  RelB-­‐/-­‐	  and	  NIK-­‐/-­‐	  mice58,	  which	  
present	  with	  defective	  medullary	  architecture,	  and	  the	  absence	  of	  CD80hi	  mature	  mTEC59.	  
Some	  data	  also	  suggests	  that	  iNKT	  development	  is	  impeded	  in	  Aire-­‐/-­‐	  mice60,	  although	  
reports	  are	  conflicting61.	  	  
	  
2.4:	  Project	  aims	  
The	  aims	  of	  this	  project	  were	  as	  follows:-­‐	  
	  
1. Identify	  the	  maturational	  stages	  associated	  with	  key	  events	  in	  iNKT	  development,	  
including	  PLZF	  expression	  and	  proliferation	  
2. Phenotype	  iNKT	  populations	  in	  the	  thymus	  and	  periphery	  of	  wildtype	  mice	  
3. Determine	  whether	  medullary	  homing	  chemokine	  receptors	  (CCR4	  and	  CCR7)	  are	  
expressed	  in	  iNKT	  
4. Examine	  the	  effects	  of	  deletion	  of	  CCR4	  and	  CCR7	  on	  development	  and	  homeostasis	  
of	  iNKT	  
	  
Section	  3.0:	  Methods	  
3.1:	  Animals	  
	   Wildtype	  C57/BL6	  (B6)	  and	  B6	  background	  Foxp3-­‐GFP	  reporter	  mice	  were	  used	  as	  
controls	  for	  B6	  background	  CCR4-­‐/-­‐,	  CCR7-­‐/-­‐	  and	  CCR4-­‐/-­‐CCR7-­‐/-­‐	  mice.	  All	  mice	  were	  housed	  in	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the	  BMSU	  under	  germ-­‐free	  conditions,	  aged	  from	  6-­‐10	  weeks,	  and	  sacrificed	  using	  a	  
schedule	  1	  method	  of	  killing.	  
	  
3.2:	  Media	  &	  reagents	  
	   RF10	  medium	  was	  used	  for	  disaggregating	  tissues,	  as	  well	  as	  re-­‐suspending	  cells	  in	  a	  
final	  volume	  for	  the	  purpose	  of	  counting,	  and	  consisted	  of	  RPMI	  medium	  (Sigma)	  with	  10%	  
heat-­‐inactivated	  fetal	  calf	  serum	  (FCS),	  2%	  penicillin	  and	  streptomycin,	  and	  1%	  glutamine.	  
“FACS	  buffer”	  was	  used	  for	  suspension	  of	  antibody	  cocktails	  in	  staining	  for	  flow	  cytometry,	  
and	  consisted	  of	  PBS	  with	  Ca2+	  and	  Mg2+	  (Sigma),	  with	  3%	  FCS.	  
	  
3.3:	  Tissue	  preparation	  for	  flow	  cytometry	  
	   Thymus,	  spleen	  and	  2x	  inguinal	  lymph	  nodes	  were	  isolated	  and	  cleaned	  of	  excess	  fat	  
and	  connective	  tissue	  under	  a	  light	  microscope	  using	  forceps.	  The	  cleaned	  organs	  were	  
disaggregated	  between	  two	  frosted	  microscope	  slides,	  and	  pipetted	  through	  a	  fine	  gauze	  
filter	  into	  a	  25ml	  falcon	  tube,	  before	  centrifugation	  (1400rpm	  for	  4	  minutes	  as	  standard).	  
Splenocytes	  were	  subjected	  to	  red	  blood	  cell	  (RBC)	  lysis	  through	  suspension	  in	  2ml	  RBC	  lysis	  
buffer	  (Sigma)	  at	  room	  temperature	  for	  5	  minutes,	  before	  neutralization	  with	  2ml	  RF10	  and	  
centrifugation.	  The	  supernatant	  was	  removed,	  and	  cells	  re-­‐suspended	  in	  a	  known	  volume	  of	  
RF10	  (5ml	  thymus	  &	  spleen,	  1ml	  lymph	  nodes),	  before	  cells	  were	  counted	  using	  counting	  
beads.	  This	  was	  done	  in	  a	  solution	  containing	  10μl	  beads	  (10^4	  beads),	  and	  100μl	  cell	  
solution,	  where	  cell	  numbers	  were	  calculated	  based	  the	  ratio	  of	  cells:beads	  in	  a	  plot	  of	  FSC	  
vs.	  SSC.	  Cell	  suspensions	  were	  stored	  on	  ice	  at	  all	  times	  except	  where	  stated.	  	  
	  
	   15	  
3.4:	  Staining	  for	  flow	  cytometry	  
	   Cells	  were	  aliquoted	  into	  1.5ml	  eppendorfs	  (5x106	  cells	  for	  samples,	  2x106	  for	  single	  
colours),	  centrifuged,	  and	  supernatant	  removed.	  Single	  colour	  samples	  -­‐	  used	  for	  
compensation	  of	  samples	  through	  the	  BD	  FACS-­‐Diva	  software	  -­‐	  were	  stained	  in	  50μl,	  and	  
samples	  100μl	  of	  staining	  solution,	  which	  consisted	  of	  antibody	  cocktails	  suspended	  in	  FACS	  
buffer.	  Samples	  were	  re-­‐suspended	  in	  200μl	  FACS	  buffer	  in	  FACS	  tubes,	  run	  on	  the	  BD	  LSR-­‐
Fortessa,	  and	  analyzed	  using	  FlowJo	  software	  v8.7.	  	  
All	  samples	  were	  first	  suspended	  in	  Fc	  block	  (CD16/32,	  BD	  biosciences,	  1:100)	  for	  20	  
minutes	  on	  ice.	  Cells	  were	  spun	  down	  and	  the	  supernatant	  removed	  prior	  to	  re-­‐suspension	  
in	  the	  first	  antibody	  stain.	  All	  stains	  were	  applied	  for	  30	  minutes	  on	  ice,	  with	  the	  exception	  
of	  CCR7	  PE,	  which	  was	  refrigerated	  for	  2hrs,	  and	  all	  were	  washed	  in	  1ml	  FACS	  buffer	  x1	  
between	  steps,	  and	  x2	  between	  intracellular	  stains	  and	  prior	  to	  final	  re-­‐suspension.	  Cells	  
were	  surface	  stained	  for	  the	  following;	  CD4,	  CD8,	  CD24,	  CD44,	  TCRβ,	  NK1.1,	  CCR4	  and	  CCR7	  
(see	  table	  1).	  iNKT	  were	  picked	  up	  using	  a	  CD1d	  tetramer	  loaded	  with	  synthetic	  αGalCer	  -­‐	  
PBS57	  loaded	  tetramer	  BV	  (NIH,	  1:200),	  or	  empty	  tetramer	  BV	  as	  a	  control.	  
Permeabilization	  and	  fixation	  of	  cells	  for	  intracellular	  staining	  was	  conducted	  using	  
the	  ”Foxp3	  staining	  buffer	  kit”	  (eBioscience),	  wherein	  cells	  were	  suspended	  in	  400μl	  “Fix	  /	  
Perm”	  buffer	  (1:3	  concentrate:	  diluent)	  for	  40mins	  (refrigerated),	  and	  washed	  x2	  in	  1ml	  1:9	  
“Perm	  /	  Wash”	  buffer.	  Intracellular	  staining	  was	  conducted	  using	  the	  following	  antibodies	  
suspended	  in	  Perm/Wash	  buffer;	  Ki67	  (or	  isotype	  control),	  mouse	  IgG1	  anti-­‐PLZF,	  rat	  anti-­‐
mouse	  IgG1	  (see	  table	  1).	  Rat	  anti-­‐mouse	  secondary	  was	  absorbed	  in	  rat	  serum	  for	  10	  
minutes	  on	  ice	  at	  1:50,	  then	  diluted	  with	  Perm/Wash	  buffer	  for	  staining.	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3.5:	  Cell	  sorting	  
	   Cells	  from	  2x	  B6	  thymi	  were	  isolated	  and	  stained	  in	  1ml	  staining	  solution	  containing	  
CD8	  FITC	  (1:200)	  for	  30	  mins	  on	  ice.	  Thymocytes	  were	  enriched	  through	  sorting	  on	  the	  CD8-­‐	  
population,	  and	  then	  stained	  in	  400μl	  for;	  NK1.1	  PE	  (1:200),	  CD44	  PeCy7	  (1:2000),	  TCRβ	  APC	  
Cy7	  (1:100),	  and	  separately	  αGalCer	  loaded	  CD1d	  tetramer	  APC	  (1:200).	  Stained	  cells	  were	  
then	  sorted	  by	  Moflo	  cell-­‐sorter	  into	  three	  maturational	  subsets	  of	  tetramer+TCRbInt	  iNKT;	  
stage	  0-­‐1	  (CD44-­‐NK1.1-­‐),	  stage	  2	  (CD44+NK1.1-­‐)	  and	  stage	  3	  (CD44+NK1.1+).	  Purity	  was	  
confirmed	  through	  analysis	  on	  BD	  FACS	  Diva	  software	  on	  the	  LSR-­‐Fortessa,	  and	  cells	  were	  
frozen	  down	  for	  storage.	  
	  
3.6:	  Quantitative	  Polymerase	  chain	  reaction	  (qPCR)	  
	   mRNA	  was	  isolated	  and	  converted	  to	  cDNA	  according	  to	  protocol	  using	  the	  MACS	  
One-­‐step	  cDNA	  kit	  (Miltenyi	  Biotech).	  qPCR	  was	  performed	  using	  2-­‐300nM	  gene	  specific	  
primers	  for	  β-­‐actin,	  CCR4,	  CCR7,	  RANKL	  and	  CD40L	  in	  a	  reaction	  buffer	  containing	  Absolute	  
qPCR	  Sybr	  mix	  without	  ROX	  reference	  dye	  (Abgene,	  AB-­‐1158),	  dH2O,	  and	  isolated	  cDNA	  in	  a	  
volume	  of	  15ul.	  Primer	  sequences	  for	  CCR4,	  CCR7,	  CD40L	  and	  RANKL	  are	  listed	  in	  table	  2.	  
Target	  genes	  were	  quantified	  relative	  to	  the	  housekeeping	  gene	  β-­‐actin,	  with	  respect	  to	  
reaction	  efficiencies,	  as	  described	  by	  Pfaffl	  in	  200162.	  cDNA	  was	  obtained	  from	  sorted	  iNKT	  
subpopulations	  (above),	  as	  well	  as	  stock	  solutions	  of	  DP	  and	  SP	  thymocytes,	  sorted	  
according	  to	  expression	  of	  CD4	  and	  CD8,	  with	  CD4	  SP	  thymocytes	  further	  subdivided	  on	  the	  
basis	  of	  CD69,	  CCR9	  and	  CCR7	  expression	  (early	  –	  CD69+CCR9+CCR7-­‐,	  intermediate	  -­‐	  
CD69+CCR9-­‐CCR7+,	  late	  -­‐	  CD69-­‐CCR9-­‐CCR7+).	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3.7:	  Statistical	  analysis	  
	   Graphical	  representation	  of	  data	  and	  statistical	  analyses	  were	  accomplished	  using	  
Prism	  6	  software	  (Graphpad),	  and	  all	  p	  values	  shown	  are	  the	  results	  of	  unpaired	  t-­‐testing,	  
where	  “ns”	  =	  non-­‐significant,	  “*”	  =	  p<0.05,	  “**”	  =	  p<0.01,	  “***”	  =	  p<0.001,	  and	  “****”	  =	  
p<0.0001.	  	  	  
4.0:	  Results	  
4.1:	  iNKT	  development	  is	  severely	  disrupted	  upon	  deletion	  of	  medullary	  homing	  chemokine	  
receptors	  
	   iNKT	  can	  be	  detected	  by	  flow	  cytometry	  by	  staining	  using	  tetrameric	  CD1d	  complexes	  
loaded	  with	  the	  synthetic	  glycolipid	  α-­‐Gal-­‐cer.	  When	  comparing	  iNKT	  populations	  in	  the	  
thymus	  of	  wildtype	  B6	  with	  CCR4-­‐/-­‐,	  CCR7-­‐/-­‐	  and	  CCR4-­‐/-­‐CCR7-­‐/-­‐	  (DKO)	  mice,	  we	  observed	  a	  
remarkable	  reduction	  in	  the	  percentage	  of	  thymocytes	  displaying	  the	  iNKT	  TCR	  in	  all	  KO	  mice	  
(fig.	  1.1).	  In	  spite	  of	  the	  established	  role	  of	  CCR4	  and	  CCR7	  in	  medullary	  homing	  of	  positively	  
selected	  cells8,14,	  no	  overt	  defects	  in	  thymocyte	  maturation	  in	  KO	  models	  have	  been	  
previously	  reported,	  and	  hence	  any	  proportional	  changes	  are	  likely	  to	  reflect	  actual	  
numerical	  differences	  (unpublished	  data).	  However,	  altered	  thymic	  architecture,	  and	  
limitations	  in	  the	  repertoire	  of	  negatively	  selected	  thymocytes	  have	  been	  observed	  in	  CCR7-­‐/-­‐	  
mice13.	  We	  did	  observe	  slight	  increases	  in	  the	  proportion	  of	  CD4+8-­‐	  TCRβHi	  thymocytes	  in	  the	  
CCR4-­‐/-­‐	  and	  DKO	  thymus	  (fig.	  1d),	  but	  these	  were	  unlikely	  to	  be	  large	  enough	  distortions	  to	  
account	  for	  the	  reduction	  in	  iNKT	  observed.	  
	   After	  positive	  selection,	  iNKT	  uniformly	  down-­‐regulate	  CD8	  to	  become	  CD4	  SP	  
(although	  CD4	  expression	  is	  then	  itself	  lost	  by	  ~50%	  of	  iNKT,	  fig.	  1.2),	  and	  follow	  a	  unique	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sequential	  program	  of	  expression	  throughout	  development.	  The	  earliest	  stages	  are	  defined	  
by	  expression	  of	  CD24	  (Stage	  0),	  which	  is	  down-­‐regulated	  (Stage	  1),	  prior	  to	  sequential	  up-­‐
regulation	  of	  CD44	  (Stage	  2)	  and	  NK1.1	  (Stage	  3).	  As	  expression	  of	  CD24	  at	  the	  early	  stages	  is	  
relatively	  heterogeneous,	  we	  divided	  iNKT	  maturational	  subsets	  into	  3	  groups;	  stage	  0-­‐1	  
(CD44-­‐NK1.1-­‐),	  stage	  2	  (CD44+NK1.1-­‐)	  and	  stage	  3	  (CD44+NK1.1+).	  In	  the	  wildtype	  thymus,	  the	  
vast	  majority	  (91.8	  ±	  1.0%)	  of	  cells	  are	  stage	  3	  (fig.	  1.1).	  However,	  there	  were	  significant	  
increases	  in	  the	  proportion	  of	  iNKT	  in	  the	  immature	  stages	  0-­‐1	  in	  all	  of	  the	  KO	  models	  
studied,	  as	  well	  as	  an	  increase	  in	  the	  percentage	  of	  iNKT	  at	  stage	  2	  in	  the	  CCR4-­‐/-­‐	  and	  CCR7-­‐/-­‐,	  
which	  was	  by	  far	  most	  evident	  in	  the	  CCR4-­‐/-­‐,	  wherein	  only	  half	  of	  cells	  were	  NK1.1+	  (fig.	  1.1).	  
By	  examining	  iNKT	  at	  each	  stage	  of	  development	  as	  a	  proportion	  of	  total	  thymocytes,	  and	  
assuming	  total	  cellularity	  is	  unchanged,	  it	  is	  possible	  to	  directly	  compare	  mature	  and	  
immature	  populations	  between	  the	  KO	  models	  (fig.	  1.2).	  This	  approach	  reveals	  iNKT	  to	  be	  
lost	  from	  stage	  0-­‐1	  onwards	  in	  the	  CCR7-­‐/-­‐	  thymus	  only,	  stage	  2	  onwards	  in	  DKO	  mice,	  and	  
with	  only	  NK1.1+	  cells	  absent	  in	  the	  CCR4-­‐/-­‐	  (fig.	  1.2).	  
	  
4.2:	  Early	  stage	  expansion	  and	  expression	  of	  the	  transcription	  factor	  PLZF	  define	  iNKT	  
development	  
Given	  the	  raised	  percentage	  of	  less	  mature	  subsets	  of	  iNKT	  in	  the	  thymus	  of	  CCR	  KO	  
mice,	  we	  wished	  to	  analyze	  the	  events	  underpinning	  iNKT	  development	  that	  may	  be	  
disrupted	  in	  the	  KOs.	  Using	  the	  marker	  Ki67	  –	  a	  nuclear	  protein	  associated	  with	  proliferation	  
–	  we	  examined	  the	  proliferation	  status	  of	  iNKT	  between	  developmental	  stages	  0	  and	  3.	  Most	  
(80%)	  of	  iNKT	  at	  stage	  0-­‐1	  were	  actively	  proliferating,	  with	  fewer	  proliferating	  cells	  present	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as	  cells	  matured	  (44%	  at	  stage	  2,	  6%	  at	  stage	  3)	  (fig.	  2).	  This	  suggests	  that	  an	  early	  
proliferative	  burst	  occurs	  immediately	  after	  positive	  selection	  on	  cortical	  DP	  thymoctes.	  
	   The	  transcription	  factor	  promyelocytic	  leukaemia	  zinc	  finger	  protein	  (PLZF)	  is	  known	  
to	  be	  the	  master	  transcription	  factor	  for	  the	  iNKT	  lineage15,	  and	  is	  both	  necessary	  and	  
sufficient	  for	  adoption	  of	  the	  distinct	  iNKT	  phenotype47.	  The	  vast	  majority	  of	  thymic	  iNKT	  
were	  shown	  to	  be	  PLZF+	  (84%),	  with	  those	  cells	  separated	  into	  two	  distinct	  populations	  –	  
PLZFHi	  and	  PLZFLo	  (fig.	  2).	  PLZF	  expression	  is	  induced	  at	  the	  earliest	  stages	  of	  development,	  
as	  40%	  of	  stage	  0-­‐1	  cells	  are	  PLZF+,	  expressing	  high	  levels	  of	  the	  protein	  (fig.	  2).	  High	  
expression	  of	  PLZF	  persists	  into	  stage	  2,	  wherein	  it	  is	  down-­‐regulated	  in	  progression	  to	  stage	  
3.	  Expression	  of	  low	  levels	  of	  PLZF	  appears	  phenotypic	  of	  mature	  iNKT,	  as	  all	  peripheral	  
(splenic)	  iNKT	  are	  PLZFLo	  (fig	  2).	  Early	  proliferation	  and	  PLZF	  expression,	  and	  subsequent	  
down-­‐regulation	  are	  key	  events	  in	  iNKT	  development	  that	  may	  be	  disrupted	  in	  the	  CCR	  KO	  
thymus.	  
	  
4.3:	  CCR4,	  but	  not	  CCR7,	  is	  directly	  expressed	  by	  cortically	  selected	  iNKT	  
	   CCR4	  and	  CCR7	  are	  involved	  in	  relocation	  to	  the	  thymic	  medulla	  prior	  to	  negative	  
selection,	  and	  hence	  are	  co-­‐expressed	  on	  SP4	  thymocytes	  (fig.	  3).	  FACs	  analysis	  of	  iNKT	  
developmental	  stages	  showed	  significant	  expression	  of	  CCR4	  on	  iNKT	  at	  stages	  0-­‐1,	  with	  
expression	  reduced	  with	  increasing	  maturity,	  as	  only	  residual	  levels	  were	  detected	  at	  stage	  
2,	  and	  protein	  expression	  was	  absent	  by	  stage	  3	  (fig.	  3).	  	  CCR7	  protein	  was	  only	  detected	  on	  
a	  minority	  (30%)	  of	  stage	  0-­‐1	  cells,	  and	  at	  neither	  of	  the	  later	  stages	  (fig.	  3).	  These	  findings	  
were	  confirmed	  through	  PCR	  of	  sorted	  iNKT	  populations	  (fig.	  4),	  wherein	  CCR4	  mRNA	  
comparable	  to	  some	  subsets	  of	  conventional	  SP4s	  was	  present	  in	  stages	  0-­‐1	  and	  2,	  but	  	   	  
	   25	  
	   26	  
	   	  
	   27	  
	  
entirely	  absent	  in	  stage	  3	  iNKT.	  CCR7	  mRNA	  was	  barely	  detectable,	  even	  at	  the	  earliest	  
stages	  of	  maturation	  (fig.	  4),	  suggesting	  that	  CCR7	  expression	  is	  very	  transient	  at	  low	  levels,	  
and	  unlikely	  to	  play	  a	  direct	  role	  in	  iNKT	  development.	  Sorted	  populations	  of	  iNKT	  were	  also	  
tested	  for	  expression	  of	  mRNA	  for	  RANKL	  and	  CD40L	  –	  two	  signals	  known	  to	  influence	  mTEC	  
development.	  Stage	  0-­‐2	  iNKT	  (but	  not	  NK1.1+	  cells)	  express	  RANK-­‐L	  at	  levels	  equivalent	  to	  
those	  seen	  on	  early	  CD4	  SPs,	  and	  iNKT	  were	  seen	  to	  express	  CD40L	  at	  all	  maturational	  
stages,	  albeit	  at	  levels	  significantly	  lower	  than	  early	  CD4	  SPs	  (fig.	  4).	  CD40L	  did	  however	  
appear	  to	  be	  up-­‐regulated	  slightly	  on	  maturation,	  and	  NK1.1+	  iNKT	  expressed	  CD40L	  at	  levels	  
equivalent	  to	  late	  CD69-­‐	  SP	  CD4s	  (fig.	  4).	  
	  
4.4:	  The	  thymic	  defect	  in	  iNKT	  is	  not	  made	  up	  in	  the	  periphery	  
Peripheral	  iNKT	  are	  largely	  phenotypically	  mature	  (although	  some	  CD44+NK1.1-­‐	  
present	  will	  still	  go	  on	  to	  express	  NK1.1),	  and	  can	  to	  some	  extent	  be	  divided	  into	  subsets	  
with	  unique	  cytokine	  expression	  based	  on	  the	  markers	  CD4	  and	  NK1.1.	  Populations	  of	  iNKT	  
in	  both	  the	  spleen	  and	  inguinal	  lymph	  nodes	  (iLNs)	  of	  CCR4,	  CCR7	  and	  DKO	  mice	  were	  
examined	  by	  FACS.	  The	  peripheral	  iNKT	  were	  again	  dramatically	  reduced	  proportionally	  –	  
the	  defect	  in	  thymic	  production	  was	  in	  no	  way	  made	  up	  through	  peripheral	  expansion	  in	  any	  
of	  the	  KO	  models	  (figs	  5-­‐6).	  The	  drop	  in	  numbers	  of	  iNKT	  present	  in	  the	  periphery	  was	  also	  
accompanied	  by	  a	  shift	  in	  NK1.1	  expression	  –	  only	  31.8±1.5%	  of	  iNKT	  are	  NK1.1-­‐	  in	  the	  
wildtype	  spleen,	  but	  this	  percentage	  was	  significantly	  higher	  in	  each	  of	  the	  CCR	  KOs,	  
particularly	  the	  CCR4-­‐/-­‐	  (fig.	  5).	  Among	  the	  NK1.1-­‐	  population,	  there	  was	  also	  a	  relative	  
reduction	  in	  the	  NK1.1/CD4	  double	  negative	  population	  in	  the	  CCR4	  KO	  spleen	  (fig.	  5).	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   Analysis	  of	  iNKT	  in	  the	  iLNs	  yielded	  no	  such	  shift	  in	  NK1.1	  expression	  (fig.	  6)	  -­‐	  
although	  fluctuation	  in	  CD4	  expressing	  cells	  was	  observed	  in	  the	  CCR7-­‐/-­‐,	  the	  very	  low	  
number	  of	  cells	  present	  largely	  devalues	  any	  phenotypic	  analysis.	  Similarly,	  it	  is	  difficult	  to	  
ensure	  loss	  of	  iNKT	  numerically	  in	  the	  CCR7-­‐/-­‐	  and	  DKO	  spleen,	  as	  CCR7	  is	  required	  for	  entry	  
of	  lymphocytes	  into	  the	  lymph	  nodes,	  and	  hence	  the	  percentage	  drop	  seen	  may	  in	  part	  be	  
attributable	  to	  retention	  of	  conventional	  lymphocytes	  in	  the	  spleen.	  This	  may	  be	  particularly	  
relevant	  given	  the	  very	  low	  proportion	  of	  iNKT	  in	  the	  wildtype	  iLNs	  (fig.	  6),	  as	  reflected	  in	  the	  
relatively	  low	  proportion	  of	  CCR7+	  iNKT	  in	  the	  spleen	  (16.1%	  vs	  91.8%	  of	  conventional	  CD4s)	  
(fig.	  7).	  	  
	   Phenotypic	  analysis	  of	  the	  iNKT	  present	  in	  the	  spleen	  may	  be	  similarly	  impeded.	  
Firstly,	  iNKT	  in	  the	  iLNs	  are	  largely	  NK1.1-­‐	  (73.2±3.4%,	  fig.	  6),	  conversely	  to	  splenic	  iNKT	  
(31.8±1.5	  NK1.1-­‐,	  fig.	  5),	  and	  hence	  retention	  would	  be	  likely	  to	  increase	  the	  proportion	  of	  
NK1.1-­‐	  cells.	  Secondly,	  CCR4	  acts	  as	  a	  lung	  homing	  receptor	  for	  both	  conventional	  T	  cells	  and	  
iNKT,	  and	  hence	  negligible	  CCR4+	  cells	  were	  observed	  among	  conventional	  splenic	  CD4s,	  nor	  
iNKT	  (fig.	  7).	  Again	  splenic	  retention	  could	  at	  least	  in	  part	  explain	  the	  reduced	  proportion	  of	  
iNKT	  in	  the	  spleen	  and	  iLNs	  (the	  lungs	  are	  relatively	  sparsely	  populated	  by	  iNKT16),	  as	  well	  as	  
the	  shift	  towards	  NK1.1-­‐	  cells,	  as	  these	  are	  relatively	  enriched	  in	  the	  lungs	  (50.2%16).	  
	  
Section	  5.0:	  Discussion	  
5.1:	  Expression	  of	  medullary-­‐homing	  chemokine	  receptors	  on	  iNKT	  
	   We	  have	  observed	  a	  dramatic	  reduction	  in	  the	  proportion	  of	  tetramer+TCRβ+	  iNKT	  in	  
the	  thymus,	  spleen	  and	  iLNs	  of	  mice	  lacking	  CCR4	  and/or	  CCR7.	  Although	  we	  were	  unable	  to	  
determine	  the	  number	  of	  cells	  present	  in	  these	  experiments,	  subsequent	  pilot	  experiments	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(not	  shown)	  have	  shown	  these	  proportional	  changes	  to	  correspond	  to	  actual	  numerical	  
absence,	  rather	  than	  the	  expansion	  of	  other	  populations,	  and	  thymic	  cellularities	  were	  
comparable	  to	  the	  wildtype.	  Although	  development	  of	  conventional	  T-­‐cells	  continues	  as	  
normal	  in	  CCR4-­‐/-­‐	  (unpublished	  data)	  and	  CCR7-­‐/-­‐	  mice14,	  these	  chemokine	  receptors	  are	  
known	  to	  play	  an	  important	  role	  by	  controlling	  relocation	  of	  positively	  selected	  populations	  
to	  the	  medulla8,14.	  This	  allows	  negative	  selection	  of	  potentially	  auto-­‐reactive	  thymocytes	  
through	  exposure	  to	  mTEC-­‐derived	  self-­‐antigens,	  and	  the	  TCR	  repertoire	  of	  peripheral	  T-­‐cells	  
in	  CCR7-­‐/-­‐	  mice	  is	  known	  to	  contain	  auto-­‐reactive	  cells	  capable	  of	  triggering	  tissue-­‐specific	  
auto-­‐immunity13.	  
	   Through	  both	  flow	  cytometry,	  and	  PCR	  using	  isolated	  mRNA	  from	  sorted	  iNKT	  
populations,	  we	  were	  able	  to	  detect	  expression	  of	  CCR4	  in	  early,	  NK1.1-­‐	  populations	  of	  iNKT	  
(stages	  0-­‐2)	  in	  the	  thymus,	  but	  not	  mature	  NK1.1+	  cells.	  All	  positively	  selected	  iNKT	  are	  
known	  to	  express	  the	  transcription	  factor	  PLZF15,	  however	  we	  have	  detected	  PLZF-­‐	  cells	  
among	  stage	  0-­‐1	  cells,	  suggesting	  some	  conventional	  SPs	  are	  present	  in	  our	  gating.	  As	  
expression	  of	  CCR7	  was	  only	  detected	  on	  very	  few	  stage	  0-­‐1	  cells	  in	  FACS,	  and	  not	  by	  PCR	  of	  
sorted	  populations	  where	  gating	  was	  more	  frugal,	  this	  suggests	  that	  the	  CCR7+	  cells	  may	  be	  
contaminating	  SPs.	  Our	  findings	  largely	  agree	  with	  a	  recent	  study,	  which	  suggests	  that	  these	  
receptors	  are	  co-­‐expressed	  on	  a	  newly	  identified	  population	  of	  IL-­‐17RB+	  iNKT,	  which	  are	  
CCR4hiCCR7low,	  and	  lie	  entirely	  within	  the	  NK1.1-­‐	  bracket	  in	  the	  thymus,	  but	  not	  IL-­‐17RB-­‐	  
cells,	  which	  are	  NK1.1+	  16.	  
	   That	  thymic	  development	  of	  iNKT	  is	  heavily	  reduced	  in	  CCR4,	  CCR7	  and	  DKO	  mice	  is	  
interesting	  in	  the	  context	  of	  previous	  work	  on	  the	  co-­‐stimulatory	  requirements	  of	  these	  
cells.	  Multiple	  studies	  have	  shown	  that	  signaling	  through	  homotypic	  interactions	  of	  SLAM	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family	  members	  SLAM	  and	  Ly108	  is	  essential	  for	  positive	  selection	  of	  iNKT29,40.	  Signals	  from	  
SLAM	  are	  transduced	  by	  the	  adapter	  protein	  SAP,	  which	  activates	  Fyn	  kinase41.	  One	  of	  the	  
downstream	  targets	  of	  Fyn	  kinase	  is	  DOCK263,	  a	  protein	  with	  known	  involvement	  in	  
cytoskeletal	  regulation,	  which	  also	  lies	  downstream	  of	  chemokine	  receptors14.	  Deletion	  of	  
any	  of	  these	  proteins	  impedes	  iNKT	  development40,41,63,	  and	  it	  may	  emerge	  that	  the	  effects	  
in	  DOCK2-­‐/-­‐	  cells	  are	  in	  part	  a	  consequence	  of	  the	  absolute	  dependence	  of	  iNKT	  on	  
chemokine	  receptor	  signaling.	  
	  
5.2:	  Potential	  explanations	  of	  disrupted	  iNKT	  development	  in	  CCR	  KO	  mice	  
	   As	  we	  failed	  to	  observe	  significant	  CCR7	  expression	  on	  iNKT,	  the	  defect	  in	  their	  
development	  we	  observed	  in	  CCR7-­‐/-­‐	  mice	  must	  be	  indirect.	  iNKT	  in	  these	  mice,	  but	  
puzzlingly	  not	  the	  DKOs,	  were	  reduced	  as	  a	  proportion	  of	  total	  T-­‐cells	  from	  the	  very	  earliest	  
stages	  (0-­‐1),	  suggesting	  a	  problem	  in	  their	  selection,	  and	  assumption	  of	  the	  iNKT	  phenotype.	  
Selection	  of	  iNKT	  requires	  interaction	  with	  DP	  thymocytes64,	  which	  co-­‐express	  CD1d	  and	  
SLAM	  family	  members29,40,	  the	  former	  of	  which	  presents	  glycolipid	  antigens24.	  iNKT	  are	  
positively	  selected	  on	  the	  condition	  they	  have	  successfully	  formed	  a	  TCR	  capable	  of	  
recognizing	  CD1d-­‐antigen	  complexes,	  which	  is	  achieved	  only	  by	  recombination	  of	  a	  limited	  
selection	  of	  gene	  segments25.	  iNKT	  TCRs	  have	  a	  common	  α-­‐chain	  (Vα14-­‐Jα18),	  and	  a	  limited	  
array	  of	  β-­‐chains	  (Vβ8.2,	  Vβ7.1,	  Vβ7.2),	  and	  are	  hence	  termed	  semi-­‐invariant25.	  As	  the	  α-­‐
chain	  rearrangement	  required	  must	  occur	  late	  on	  in	  DP	  recombination,	  iNKT	  are	  highly	  
susceptible	  to	  factors	  that	  reduce	  the	  t1/2	  of	  DP	  cells29.	  The	  agonist	  ligands	  for	  positive	  
selection	  themselves	  have	  so	  far	  remained	  somewhat	  elusive,	  although	  evidence	  for	  the	  
involvement	  of	  iGb3	  and	  βGlcCer	  is	  mounting24,65.	  	  
	   32	  
	   It	  is	  well	  established	  that	  development	  of	  conventional	  T-­‐cells	  proceeds	  as	  normal	  in	  
CCR7-­‐/-­‐	  mice,	  but	  SP	  thymocytes,	  which	  we	  have	  confirmed	  strongly	  express	  both	  CCR4	  and	  
CCR7,	  fail	  to	  relocate	  to	  the	  medulla	  after	  negative	  selection13,14.	  These	  cells	  may	  contribute	  
to	  the	  failure	  of	  iNKT	  selection	  by	  competing	  for	  survival	  factors,	  and	  hence	  reducing	  the	  
lifespan	  of	  DP	  thymocytes,	  although	  normal	  DP	  numbers	  are	  present	  in	  CCR7-­‐/-­‐s14.	  Gene	  
expression	  data-­‐browser	  Immgen	  suggests	  that	  expression	  of	  CD1d	  persists	  at	  similar	  levels	  
on	  SP	  thymocytes66,	  although	  little	  is	  known	  about	  the	  capacity	  of	  these	  cells	  to	  express	  
agonists	  and	  co-­‐stimulatory	  molecules,	  and	  indeed	  mediate	  positive	  and	  negative	  selection	  
of	  iNKT.	  Dendritic	  cells	  are	  known	  to	  produce	  differential	  arrays	  of	  glycolipids	  dependent	  on	  
their	  state	  of	  activation67,	  and	  hence	  it	  seems	  conceivable	  that	  SP	  thymocytes	  could	  express	  
ligands	  at	  a	  higher	  density,	  or	  with	  a	  higher	  affinity,	  or	  instead	  differentially	  express	  co-­‐
stimulatory	  molecules:	  factors	  which	  could	  raise	  the	  propensity	  for	  negative	  selection	  of	  
iNKT	  upon	  retention	  of	  these	  cells	  in	  the	  cortex.	  Through	  transgenic	  over-­‐expression	  of	  
CD1d,	  Chun	  et	  al.32	  established	  that	  a	  bone	  marrow	  (BM)-­‐derived	  population,	  rather	  than	  
thymic	  epithelial	  cells,	  was	  responsible	  for	  negative	  selection	  of	  iNKT	  through	  creation	  of	  
CD1d-­‐/-­‐àWT	  and	  WTàCD1d-­‐/-­‐	  BM	  chimeras.	  The	  paper	  then	  went	  on	  to	  establish	  that	  DCs	  
could	  negatively	  select	  iNKT	  when	  co-­‐transferred	  with	  BM	  cells	  into	  an	  irradiated	  
lymphopenic	  host,	  as	  greater	  deletion	  was	  seen	  on	  transgenic	  overexpression	  of	  CD1d	  in	  
sorted	  DCs,	  but	  didn’t	  address	  the	  possibility	  that	  similarly	  bone	  marrow-­‐derived	  thymocyte	  
populations	  could	  make	  a	  contribution32.	  Greater	  difficulty	  lies	  in	  proving	  negative	  selection	  
by	  SPs,	  as	  they	  are	  derived	  from	  the	  same	  precursors	  as	  iNKT	  themselves,	  and	  would	  likely	  
require	  overexpression	  of	  CD1d	  under	  the	  control	  of	  a	  promoter	  specific	  to	  SP	  thymocytes.	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   Another	  possibility	  for	  the	  absence	  of	  early	  iNKT	  in	  CCR7-­‐/-­‐	  mice	  may	  be	  transient	  
expression	  of	  CCR7	  prior	  to	  down-­‐regulation	  of	  CD8	  –	  this	  would	  account	  for	  the	  discrepancy	  
in	  CCR7	  expression	  we	  observed	  between	  FACS,	  wherein	  DP	  cells	  already	  to	  have	  up-­‐
regulated	  TCR	  expression	  were	  included	  in	  our	  analysis,	  and	  PCR,	  where	  sorted	  populations	  
were	  enriched	  for	  CD8-­‐	  cells.	  It	  is	  well	  established	  that	  DP	  thymocytes	  are	  confined	  to	  the	  
thymic	  cortex,	  but	  although	  rare	  DP	  thymocytes	  do	  express	  CCR768,	  a	  role	  for	  it’s	  expression	  
has	  yet	  to	  be	  established.	  Cortical	  expression	  of	  CCL21	  -­‐	  a	  CCR7	  ligand	  –	  does	  occur,	  but	  is	  
restricted	  to	  the	  areas	  surrounding	  the	  vasculature69.	  Using	  CD11c-­‐YFP	  reporter	  mice,	  
combined	  with	  two-­‐photon	  laser	  scanning	  microscopy,	  Ladi	  et	  al.	  recently	  identified	  a	  
population	  of	  DCs	  that	  co-­‐localize	  with	  CCL21	  in	  the	  cortex69.	  Interactions	  between	  cortical	  
DCs	  and	  DP	  thymocytes	  were	  frequent,	  and	  observed	  to	  be	  largely	  dependent	  on	  CCR7	  
expression69.	  The	  purpose	  of	  these	  interactions	  is	  currently	  unknown,	  but	  as	  CCR7	  
expression,	  like	  the	  iNKT	  TCR,	  is	  rare	  in	  DP	  thymocytes,	  it	  would	  be	  interesting	  to	  establish	  
whether	  iNKT	  are	  part	  of	  the	  make-­‐up	  of	  CCR7+DP	  thymocytes.	  As	  tetramer	  staining	  in	  tissue	  
sections	  has	  proven	  difficult,	  determining	  the	  cortical	  localization	  of	  iNKT	  immediately	  post-­‐
positive	  selection	  in	  respect	  to	  CD11c+	  DCs	  may	  be	  possible	  using	  antibodies	  against	  PLZF	  
and	  CD24.	  
	   In	  contrast	  to	  the	  CCR7-­‐/-­‐,	  we	  observed	  positive	  selection	  of	  iNKT	  to	  continue	  at	  
normal	  levels	  in	  mice	  lacking	  both	  CCR4	  and	  CCR7,	  but	  these	  cells	  were	  proportionally	  
reduced	  in	  the	  thymus	  from	  stage	  2.	  During	  stage	  1-­‐2,	  iNKT	  up-­‐regulate	  CD44,	  and	  undergo	  
rounds	  of	  proliferation52,	  as	  we	  have	  confirmed	  using	  the	  nuclear	  marker	  Ki67.	  Ki67+	  cells	  
represented	  the	  majority	  of	  stage	  0-­‐1	  iNKT,	  but	  were	  less	  abundant	  after	  up-­‐regulation	  of	  
CD44,	  and	  a	  minority	  of	  cells	  among	  the	  NK1.1+	  population.	  Multiple	  intracellular	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components	  have	  been	  identified	  as	  essential	  for	  this	  proliferative	  burst,	  including	  cell	  cycle	  
regulator	  c-­‐Myc52,70,	  and	  NFκB	  member	  RelA53,	  which	  controls	  γC	  expression,	  sensitizing	  
CD44low	  iNKT	  to	  IL-­‐15	  and	  IL-­‐7	  signaling53,	  which	  along	  with	  TGFβ	  appear	  to	  drive	  
expansion27,31.	  Co-­‐stimulatory	  signals	  are	  important	  in	  initiating	  this	  process	  –	  in	  spite	  of	  
normal	  numbers	  of	  CD24+	  post-­‐selection	  iNKT,	  these	  cells	  fail	  to	  expand	  in	  both	  CD80/86-­‐/-­‐	  
and	  ICOSL-­‐/-­‐	  mice50	  (although	  this	  second	  finding	  has	  recently	  been	  contradicted57),	  and	  
expression	  of	  CD28,	  the	  receptor	  for	  CD80/86,	  is	  required	  on	  both	  iNKT	  and	  conventional	  T-­‐
cells	  for	  optimal	  proliferative	  responses42,50.	  	  
	   Although	  it	  is	  difficult	  to	  speculate	  why	  iNKT	  are	  successfully	  positively	  selected	  in	  
these	  mice,	  but	  not	  the	  CCR7-­‐/-­‐,	  it	  is	  tempting	  to	  suggest	  that	  these	  cells	  fail	  to	  receive	  the	  
retinue	  of	  cytokine	  and	  co-­‐stimulatory	  signaling	  required	  for	  proliferation	  –	  this	  could	  easily	  
be	  established	  by	  staining	  the	  few	  cells	  present	  for	  Ki67	  or	  by	  intra-­‐thymic	  BrDu	  injection.	  
Within	  the	  thymus,	  IL-­‐15,	  CD80/86	  and	  ICOSL	  are	  both	  largely	  expressed	  by	  mTEC	  and	  DCs	  in	  
the	  medulla55,71,72,	  whereas	  TGFβ	  is	  ubiquitously	  expressed	  in	  most	  tissues.	  As	  CCR4	  
expression	  is	  likely	  required	  by	  iNKT	  to	  undertake	  the	  cortex-­‐medulla	  transition,	  cortical	  
retention	  and	  limitation	  of	  these	  factors	  would	  seem	  a	  likely	  cause	  for	  the	  failure	  of	  these	  
cells	  to	  expand.	  However,	  stage	  0-­‐2	  iNKT	  are	  present	  in	  proportions	  equivalent	  to	  the	  WT	  in	  
CCR4-­‐/-­‐	  mice	  –	  here	  retention	  of	  SP	  thymocytes	  in	  the	  medulla	  is	  likely	  to	  be	  less	  severe,	  as	  
their	  chemotaxis	  towards	  CCR7	  ligands	  is	  much	  stronger	  than	  CCR48.	  It	  may	  therefore	  be	  the	  
case	  that	  SP	  thymocytes	  -­‐	  which	  up-­‐regulate	  some	  IL-­‐receptors	  on	  positive	  selection73	  –	  
remain	  in	  the	  cortex	  alongside	  iNKT	  in	  DKO	  mice,	  and	  out-­‐compete	  iNKT	  for	  factors	  driving	  
their	  proliferation	  which	  are	  more	  abundantly	  expressed	  in	  the	  medulla.	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   Large	  numbers	  of	  iNKT	  were	  seen	  to	  express	  CCR4,	  although	  expression	  was	  lost	  with	  
increasing	  maturity,	  and	  absent	  in	  NK1.1+	  cells	  in	  the	  thymus.	  iNKT	  were	  seen	  in	  normal	  
proportions	  within	  total	  thymocytes	  at	  stages	  0-­‐2,	  but	  NK1.1+	  cells	  were	  conspicuously	  
absent.	  A	  similar	  phenotype	  has	  previously	  been	  observed	  in	  Aire-­‐/-­‐	  mice60,	  where	  medullary	  
production	  of	  the	  ligands	  for	  CCR4	  (and	  CCR7)	  is	  reduced11.	  It	  therefore	  seems	  likely,	  given	  
the	  involvement	  of	  CCR4	  in	  trafficking	  of	  conventional	  SP	  thymocytes	  to	  the	  medulla,	  that	  a	  
factor	  expressed	  exclusively	  within	  the	  medulla	  is	  essential	  for	  the	  up-­‐regulation	  of	  NK1.1	  
expression	  on	  mature	  populations	  of	  iNKT.	  However,	  it	  would	  be	  difficult	  to	  conclusively	  
prove	  that	  this	  defect	  is	  intrinsic	  to	  iNKT	  without	  selective	  CCR4	  deletion	  –	  this	  could	  in	  
theory	  be	  achieved	  through	  generation	  of	  a	  transgenic	  mouse	  expressing	  CRE	  recombinase	  
under	  the	  control	  of	  PLZF	  promoter,	  although	  other	  unconventional	  T-­‐cell	  types	  would	  be	  
similarly	  affected31.	  As	  mentioned	  above,	  PLZF	  could	  be	  a	  candidate	  for	  locating	  iNKT	  in	  
sections	  of	  WT	  and	  CCR4-­‐/-­‐	  thymi.	  
	   Progression	  to	  stage	  3	  is	  known	  to	  be	  dependent	  on	  CD1d33,48,	  as	  TCR	  signaling	  
activates	  RelA,	  and	  subsequently	  CD122	  expression,	  for	  formation	  of	  the	  IL-­‐15	  receptor53.	  
Although	  homeostasis	  of	  NK1.1+	  iNKT	  requires	  IL-­‐1555,	  continued	  antigen	  recognition	  is	  not	  
required,	  as	  demonstrated	  by	  the	  persistence	  of	  NK1.1+	  cells	  transferred	  into	  CD1d-­‐/-­‐	  mice33.	  
Similar	  transfer	  experiments	  could	  be	  used	  to	  investigate	  whether	  it	  is	  survival	  or	  formation	  
of	  NK1.1+	  cells	  in	  the	  thymus	  that	  is	  compromised	  by	  CCR4	  deletion.	  In	  either	  case,	  if	  IL-­‐15	  is	  
the	  limiting	  factor,	  admission	  of	  exogenous	  IL-­‐15R-­‐stimulating	  antibody	  would	  be	  expected	  
to	  restore	  the	  presence	  of	  NK1.1+	  cells	  (as	  IL-­‐15	  requires	  trans-­‐presentation55,	  exogenous	  IL-­‐
15	  alone	  is	  unlikely	  to	  be	  effective).	  We	  have	  confirmed	  previous	  reports15	  that	  iNKT	  down-­‐
regulate	  PLZF	  expression	  when	  reaching	  full	  maturity,	  and	  all	  mature	  thymic	  and	  peripheral	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iNKT	  are	  PLZFlow.	  PLZF	  controls	  the	  expression	  of	  memory	  markers,	  including	  those	  involved	  
in	  tissue	  localization47,	  and	  is	  also	  believed	  to	  control	  the	  down-­‐regulation	  of	  CD4	  in	  iNKT	  
development47,	  as	  all	  PLZF-­‐/-­‐	  iNKT	  are	  CD4+.	  Intriguingly,	  we	  observed	  a	  significant	  skew	  in	  
CD4	  expression	  in	  NK1.1-­‐	  thymocytes	  towards	  CD4+	  cells.	  NK1.1+CD4-­‐	  cells,	  which	  were	  
proportionally	  reduced	  (most	  notably	  in	  the	  CCR4-­‐/-­‐),	  largely	  consist	  of	  IL-­‐17RB+RORgt+	  iNKT	  
capable	  of	  producing	  IL-­‐1716,	  although	  few	  precursors	  to	  NK1.1+	  cells	  are	  likely	  present.	  	  
	   As	  PLZF	  likely	  plays	  a	  role	  in	  both	  switching	  off	  CD4	  expression,	  as	  well	  as	  generating	  
NK1.1+	  iNKT,	  it	  is	  tempting	  to	  assume	  that	  expression	  of	  PLZF	  is	  dysregulated	  in	  CCR4-­‐/-­‐	  iNKT,	  
although	  this	  has	  been	  difficult	  to	  corroborate,	  as	  iNKT	  are	  so	  few	  in	  the	  CCR4-­‐/-­‐	  thymus,	  and	  
both	  cell	  numbers	  and	  tetramer	  staining	  are	  substantially	  lost	  in	  the	  permeabilization	  
process	  involved	  in	  PLZF	  staining.	  That	  CD4-­‐	  cells	  are	  proportionally	  lost	  in	  all	  CCR-­‐/-­‐	  mice	  may	  
reflect	  differential	  requirements	  of	  the	  newly	  established	  IL-­‐17RB+	  subset	  of	  iNKT.	  These	  
cells	  develop	  normally	  in	  IL-­‐15-­‐/-­‐	  mice16,	  utilize	  alternative	  pathways	  in	  TGFβ	  signaling	  during	  
development27,	  and	  their	  cytokine	  secretion	  is	  defined	  by	  CD4	  expression	  –	  CD4+	  cells	  
produce	  Th2,	  Th9	  and	  Th17	  cytokines,	  whereas	  CD4-­‐	  express	  IL-­‐1716.	  It	  has	  been	  suggested	  
that	  these	  cells	  evolve	  from	  a	  distinct	  developmental	  pathway,	  as	  early	  RORgt+	  iNKT	  cannot	  
go	  on	  to	  form	  RORgt-­‐	  or	  NK1.1+	  populations	  in	  culture28.	  That	  both	  the	  proportion	  of	  iNKT	  of	  
the	  CD4-­‐NK1.1-­‐	  phenotype	  and	  mature	  NK1.1+	  iNKT	  as	  a	  whole	  are	  reduced	  suggests	  that	  
both	  pathways	  are	  severely	  inhibited	  upon	  CCR	  deletion.	  
	   As	  iNKT	  are	  seen	  to	  be	  so	  severely	  depleted	  in	  the	  thymus	  it	  seems	  highly	  likely	  that	  
the	  reduced	  proportions	  observed	  in	  the	  spleen	  and	  iLNs	  were	  as	  a	  result	  of	  failed	  
generation,	  rather	  than	  problems	  with	  homeostatis,	  especially	  as	  experiments	  by	  our	  lab	  
have	  demonstrated	  limited	  rebound	  expansion	  among	  iNKT	  in	  lymphopenic	  mice	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(unpublished	  data).	  The	  reduction	  of	  iNKT	  among	  T-­‐cells	  was	  equivalent	  in	  all	  three	  KO	  mice,	  
with	  the	  exception	  of	  the	  CCR4-­‐/-­‐	  iLNs,	  which	  were	  slightly	  more	  depleted	  of	  tetramer+	  cells,	  
potentially	  reflecting	  the	  severe	  skew	  in	  CD4	  expression	  in	  the	  thymus	  of	  these	  mice,	  as	  
NK1.1-­‐CD4-­‐	  cells	  largely	  localize	  to	  the	  lungs	  and	  LNs16,45.	  The	  reduction	  in	  iNKT	  was	  also	  
most	  dramatic	  in	  the	  iLNs	  out	  of	  all	  3	  tissues,	  which	  is	  unsurprising,	  as	  the	  majority	  of	  LN	  
iNKT	  are	  thought	  to	  be	  recent	  thymic	  emigrants45,	  and	  would	  therefore	  directly	  reflect	  
thymic	  output.	  	  
	   Without	  confirming	  numbers	  of	  iNKT	  rather	  than	  percentages,	  it	  remains	  difficult	  to	  
determine	  whether	  these	  are	  genuinely	  smaller	  populations	  of	  cells,	  as	  CCR4	  and	  CCR7	  are	  
homing	  molecules	  in	  the	  periphery,	  directing	  T-­‐cells	  to	  the	  lungs	  and	  skin,	  and	  LNs	  
respectively16,20.	  Failure	  of	  conventional	  cells	  to	  enter	  their	  target	  tissues	  could	  raise	  their	  
cell	  numbers	  in	  the	  spleen,	  diluting	  iNKT.	  Similarly,	  CCR4	  and	  CCR7	  are	  homing	  receptors	  for	  
iNKT,	  thought	  to	  be	  expressed	  exclusively	  by	  NK1.1-­‐IL-­‐17RB+	  cells16.	  Consistent	  with	  this,	  we	  
found	  significant	  levels	  of	  expression	  of	  CCR7	  on	  iNKT	  in	  the	  lymph	  nodes	  (largely	  NK1.1-­‐),	  
but	  very	  low	  levels	  in	  the	  spleen,	  where	  the	  majority	  are	  NK1.1+.	  We	  failed	  to	  detect	  CCR4	  
expression	  on	  peripheral	  iNKT,	  likely	  as	  a	  result	  of	  these	  cells	  homing	  to	  the	  lungs.	  The	  
representation	  of	  these	  populations	  in	  the	  periphery	  could	  be	  fully	  elucidated	  using	  IL-­‐17RB	  
as	  a	  marker,	  and	  obtaining	  accurate	  total	  cell	  counts.	  	  
	  
5.3:	  Conclusion	  
	   Our	  finding	  that	  CCR4	  expression	  is	  required	  on	  iNKT	  specifically	  for	  stage	  3	  
progression,	  known	  to	  be	  dependent	  on	  medullary-­‐expressed	  IL-­‐15,	  suggests	  that	  relocation	  
of	  cells	  to	  the	  medulla	  plays	  an	  important	  role	  in	  the	  maturation	  of	  iNKT.	  iNKT	  have	  been	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found	  to	  be	  reduced	  in	  mice	  with	  defects	  in	  medullary	  development	  –	  RelB-­‐/-­‐	  58,	  NIK-­‐/-­‐	  58,	  Aire-­‐
/-­‐	  60	  and	  now	  CCR7-­‐/-­‐	  mice,	  which	  are	  known	  to	  have	  altered	  medullary	  architecture14.	  It	  is	  
possible	  that	  this	  comes	  as	  a	  result	  of	  failure	  of	  SP	  thymocytes	  to	  enter	  the	  medulla,	  as	  they	  
are	  known	  to	  provide	  CD40L,	  a	  signal	  required	  for	  mTEC	  maturation2.	  However,	  we	  have	  
observed	  NK1.1+	  iNKT,	  which	  are	  known	  to	  be	  a	  resident	  population	  within	  the	  thymus44,	  to	  
express	  both	  CD40L	  and	  RANKL,	  the	  latter	  of	  which	  is	  utilized	  by	  lymphoid	  tissue	  inducer	  
cells	  (LTi)	  to	  initiate	  development	  of	  the	  mature	  medulla2.	  Thymic	  size	  is	  reduced	  by	  ~25%	  in	  
PLZF-­‐/-­‐	  mice,	  and	  NK1.1-­‐	  iNKT	  have	  also	  been	  shown	  to	  be	  capable	  of	  producing	  IL-­‐2216,	  a	  
trophic	  factor	  also	  produced	  by	  LTi,	  and	  thought	  to	  induce	  TEC	  turnover	  for	  post-­‐stress	  
thymic	  recovery74.	  It	  is	  therefore	  possible	  that,	  as	  well	  as	  being	  affected	  by	  dysregulation	  of	  
thymic	  stromal	  cell	  development,	  iNKT	  contribute	  to	  maturation	  and	  proliferation	  of	  TEC	  
populations,	  which	  are	  disrupted	  in	  their	  absence	  in	  CCR7-­‐/-­‐	  mice.	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Abstract	  
	   Natural	  regulatory	  T-­‐cell	  (nTreg)	  are	  a	  T-­‐cell	  subset	  developed	  in	  the	  thymus	  which	  
possess	  the	  unique	  capability	  to	  actively	  suppress	  antigen-­‐specific	  CD4	  responses	  in	  the	  
periphery,	  which	  have	  been	  shown	  to	  be	  essential	  in	  the	  prevention	  of	  auto-­‐immunity	  
through	  deletion	  of	  their	  lineage-­‐defining	  transcription	  factor	  Foxp3.	  Foxp3+	  nTreg	  possess	  
T-­‐cell	  receptors	  (TCRs)	  with	  high	  auto-­‐reactivity	  relative	  to	  conventional	  cells,	  and	  are	  
believed	  to	  require	  strong	  TCR-­‐ligation	  and	  co-­‐stimulation	  during	  negative	  selection	  for	  the	  
production	  of	  CD25+	  precursors.	  More	  recently,	  it	  has	  been	  demonstrated	  that	  peripheral	  
Treg	  are	  a	  heterogenous	  population,	  consisting	  of	  death-­‐prone,	  as	  well	  as	  highly	  suppressive	  
effector-­‐memory	  subsets,	  which	  can	  be	  separated	  on	  the	  basis	  of	  expression	  of	  the	  
activation	  markers	  ICOS	  and	  CD44.	  In	  this	  study,	  we	  have	  demonstrated	  ICOS+CD44+	  memory	  
Treg	  to	  have	  unique	  homeostatic	  requirements	  from	  conventional	  CD4	  memory	  cells,	  which	  
depend	  on	  provision	  of	  co-­‐stimulation	  by	  TNF	  superfamily	  members	  CD30L	  and	  OX40L	  for	  
survival.	  We	  did	  however	  discover	  a	  role	  for	  OX40	  signaling	  in	  development	  of	  nTreg,	  as	  well	  
as	  establishing	  redundancy	  in	  mTEC	  expression	  of	  the	  co-­‐stimulatory	  molecules	  CD80/86	  and	  
ICOSL,	  the	  former	  of	  which	  has	  been	  identified	  as	  a	  key	  molecule	  for	  generation	  of	  both	  
nTreg	  precursors	  and	  ICOShiCD44hi	  Treg.	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Section	  2.0:	  Introduction	  
2.1:	  Thymic	  development	  of	  natural	  regulatory	  T	  cells	  
	   Regulatory	  T	  cells	  (Treg)	  are	  a	  phenotypically	  distinct	  population	  characterized	  by	  
their	  expression	  of	  CD25,	  as	  well	  as	  the	  transcription	  factor	  Forkhead	  Box	  P3	  (Foxp3)1.	  Treg	  
are	  capable	  of	  mediating	  Foxp3	  dependent	  antigen	  specific	  suppression	  of	  T	  cell	  responses	  
through	  secretion	  of	  cytokines	  (including	  IL-­‐10	  and	  TGFβ)2	  and	  expression	  of	  cell	  surface	  
receptors	  (CTLA-­‐4)3.	  The	  suppressive	  function	  of	  Treg	  has	  been	  repeatedly	  demonstrated	  to	  
be	  essential	  in	  preventing	  T	  cell	  mediated	  auto-­‐immunity,	  as	  observed	  upon	  neonatal	  
thymectomy4	  (as	  the	  appearance	  of	  peripheral	  Treg	  is	  delayed	  relative	  to	  conventional	  T	  
cells),	  and	  particularly	  severely	  in	  Foxp3-­‐/-­‐	  and	  Foxp3	  mutant	  “scurfy”	  mice5.	  Two	  main	  
pathways	  for	  Treg	  production	  are	  known;	  Foxp3	  expression	  can	  be	  triggered	  intrathymically	  
from	  immature	  thymocyte	  populations	  to	  produce	  natural	  Treg	  (nTreg,	  generation	  of	  which	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is	  the	  main	  focus	  of	  this	  study),	  or	  instead	  induced	  in	  naïve	  peripheral	  T	  cells	  (iTreg)	  through	  
interaction	  with	  tolerizing	  dendritic	  cell	  (DC)	  populations.	  
	   Thymic	  T	  cell	  development	  is	  a	  multistage	  process,	  consisting	  of	  checkpoints	  
involving	  recognition	  of	  antigen	  bound	  MHC	  complexes	  on	  the	  surface	  of	  thymic	  epithelial	  
cell	  (TEC)	  populations	  via	  the	  newly	  formed	  T	  cell	  receptor	  (TCR).	  The	  thymus	  is	  divided	  into	  
two	  sub-­‐compartments;	  the	  cortex	  and	  the	  medulla,	  which	  play	  residence	  to,	  and	  are	  
defined	  by,	  unique	  populations	  of	  TEC,	  cortical	  (cTEC)	  and	  medullary	  (mTEC)6,7.	  Bone	  marrow	  
derived	  T	  cell	  precursors	  enter	  the	  thymus	  at	  the	  cortico-­‐medullary	  junction,	  and	  pass	  
through	  the	  cortex	  while	  undergoing	  several	  key	  developmental	  steps	  that	  result	  in	  
formation	  of	  a	  TCR	  of	  unique	  specificity8,	  as	  well	  as	  up-­‐regulation	  of	  CD4	  and	  CD8,	  which	  act	  
as	  co-­‐receptors	  for	  MHC	  class	  II	  and	  class	  I	  respectively9.	  These	  cells	  are	  described	  as	  
CD4/CD8	  double	  positive	  (DP),	  and	  require	  survival	  signals	  from	  ligation	  of	  a	  successfully	  
formed	  TCR	  by	  cTEC	  displayed	  MHC	  in	  a	  process	  known	  as	  positive	  selection10.	  These	  cells	  
then	  down-­‐regulate	  either	  CD4	  or	  CD8	  to	  become	  single	  positive	  (SP)	  thymocytes,	  and	  traffic	  
to	  the	  thymic	  medulla,	  where	  they	  undergo	  further	  selection	  by	  mTEC	  and	  DCs11.	  	  
	   mTEC	  are	  capable	  of	  promiscuously	  expressing	  tissue	  restricted	  self-­‐antigens,	  
partially	  under	  the	  control	  of	  the	  autoimmune	  regulator	  (Aire)12,	  allowing	  determination	  of	  
the	  fate	  of	  SP	  thymocytes	  based	  on	  strength	  of	  their	  recognition	  of	  self-­‐antigen,	  and	  hence	  
the	  potential	  for	  auto-­‐reactivity	  in	  the	  periphery.	  Medullary	  DCs	  are	  also	  capable	  of	  
obtaining	  and	  cross-­‐presenting	  these	  antigens13,	  and	  contribute	  to	  selection14.	  If	  TCR	  
signaling	  strength	  is	  over	  a	  certain	  threshold	  level,	  thymocytes	  are	  deleted,	  however	  some	  
cells	  escape	  this	  process11,	  hence	  the	  requirement	  for	  Treg.	  The	  TCR	  repertoire	  of	  Treg	  is	  
distinct	  from	  that	  of	  conventional	  CD4+	  T	  cells,	  possessing	  higher	  self-­‐reactivity15;	  formation	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of	  CD25+Foxp3-­‐	  Treg	  precursors	  is	  induced	  by	  strong	  TCR	  ligation	  below	  the	  threshold	  for	  
negative	  selection15.	  Treg	  are	  known	  to	  be	  reduced	  in	  the	  Aire-­‐/-­‐	  thymus16,	  although	  recent	  
data	  suggest	  that	  this	  is	  through	  loss	  of	  the	  Aire	  dependent	  DC	  chemo-­‐attractant	  XCL1,	  and	  
the	  absence	  of	  DC	  accumulations	  in	  the	  thymic	  medulla,	  rather	  than	  auto-­‐antigen	  
expression17.	  	  
	   Selection	  of	  Treg	  is	  thought	  to	  be	  a	  2-­‐step	  process18;	  the	  first	  step	  consists	  of	  
commitment	  to	  the	  Treg	  lineage,	  mediated	  by	  strong	  TCR	  ligation15	  and	  essential	  CD80/86-­‐
CD28	  costimulation18,19,20	  (common	  to	  murine	  and	  human	  Treg	  development21),	  causing	  up-­‐
regulation	  of	  CD25	  -­‐	  the	  alpha	  chain	  of	  the	  IL-­‐2	  receptor	  –	  and	  c-­‐Rel	  dependent	  formation	  of	  
Treg	  precursors22.	  This	  in	  turn	  renders	  newly	  formed	  precursors	  receptive	  to	  γc	  cytokine	  
signals,	  which	  trigger	  Foxp3	  expression	  in	  precursors18,	  with	  IL-­‐2	  dependency	  a	  lasting	  trait	  
of	  mature	  nTreg23,	  which	  are	  marked	  by	  expression	  of	  Neuropilin-­‐124.	  Several	  factors	  
expressed	  in	  the	  thymic	  medulla	  have	  been	  shown	  to	  play	  an	  important	  role	  in	  production	  of	  
precursors,	  and	  induction	  of	  Foxp3	  expression.	  Deletion	  of	  CD80/86	  greatly	  reduces	  thymic	  
precursors20,	  and	  has	  a	  secondary	  effect	  on	  the	  development	  and	  homeostasis	  of	  Foxp3+	  
cells	  as	  it	  reduces	  conventional	  CD4	  production	  of	  IL-­‐218.	  CD70	  is	  another	  co-­‐stimulatory	  
ligand	  expressed	  by	  mTECs	  and	  DCs.	  It	  is	  expressed	  on	  all	  Aire+,	  and	  some	  Aire-­‐	  mTEC,	  
although	  it	  is	  not	  yet	  known	  whether	  CD70+Aire-­‐	  cells	  are	  precursors	  yet	  to	  initiate	  Aire	  
expression25.	  It	  does	  however	  appear	  certain	  that	  expression	  on	  both	  mTEC	  and	  CD8α+	  DCs	  
is	  essential	  for	  development	  of	  normal	  numbers	  of	  nTreg,	  with	  the	  defect	  in	  CD27-­‐/-­‐	  thymi	  
causing	  loss	  of	  Foxp3+	  cells	  rather	  than	  precursors,	  although	  Foxp3	  expression	  itself	  is	  CD27	  
independent25.	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   CD40-­‐CD40L	  interactions	  are	  also	  thought	  to	  play	  crucial	  but	  indirect	  roles	  in	  
homeostasis	  of	  thymic	  Treg.	  CD40-­‐/-­‐	  mice	  show	  greatly	  reduced	  thymic	  Treg	  in	  the	  adult,	  but	  
not	  newborn	  thymus,	  a	  puzzle	  solved	  neatly	  by	  analysis	  of	  CD40-­‐/-­‐RAG-­‐2p-­‐GFP	  Treg,	  wherein	  
GFP	  expression	  lingers	  in	  cells	  (t1/2	  56hrs)	  after	  TCR	  rearrangements,	  allowing	  determination	  
of	  newly	  formed	  and	  resident/recirculating	  populations	  in	  the	  thymus23.	  60%	  of	  Treg	  were	  
seen	  to	  be	  GFP-­‐,	  and	  it	  was	  this	  resident	  population	  only	  which	  was	  affected	  upon	  deletion	  
of	  CD40,	  apparently	  as	  a	  result	  of	  depleted	  IL-­‐2	  expression23.	  The	  loss	  of	  CD40	  had	  a	  minimal	  
effect	  on	  generation	  of	  new	  Treg23,	  but	  the	  observation	  of	  a	  dominant	  GFP-­‐	  subset	  of	  Treg	  in	  
the	  thymus	  poses	  the	  question	  of	  whether	  these	  cells	  are	  resident	  to	  the	  thymus,	  undergo	  
prolonged	  intrathymic	  maturation	  relative	  to	  conventional	  cells,	  or	  recirculate	  from	  the	  
periphery.	  	  
	   The	  medulla	  is	  thought	  to	  play	  a	  central	  role	  in	  the	  selection	  of	  Treg;	  ontogeny	  
correlates	  to	  medullary	  development	  in	  newborns26,	  mice	  with	  disrupted	  medullary	  
development	  have	  known	  defects	  in	  Treg26	  and	  expression	  of	  some	  important	  co-­‐stimulatory	  
molecules	  such	  as	  CD70	  is	  restricted	  to	  the	  medulla25.	  However	  it	  is	  worth	  noting	  that	  Foxp3+	  
cells	  are	  seen	  among	  DP	  thymocytes	  –	  be	  it	  in	  greatly	  reduced	  proportions	  –	  and	  may	  
contribute	  to	  the	  pool	  of	  SP	  cells.	  A	  recent	  paper	  by	  our	  lab	  provided	  great	  evidence	  for	  
medullary	  dependence	  through	  grafting	  of	  Relb-­‐/-­‐	  thymi	  (which	  fail	  to	  develop	  mTEC)	  under	  
the	  kidney	  capsule	  of	  wildtype	  mice27.	  In	  these	  mice,	  generation	  of	  Foxp3-­‐	  precursors	  and	  
Treg	  were	  both	  greatly	  inhibited,	  but	  a	  low	  level	  of	  generation	  was	  still	  detected27,	  possibly	  
reflecting	  the	  contribution	  of	  cortical	  selection.	  Altered	  TCR	  repertoire	  selection	  and	  
abrogation	  of	  diabetes	  in	  NOD	  mice	  upon	  the	  deletion	  of	  the	  thymus	  restricted	  serine	  
protease	  PRSS16,	  expression	  of	  which	  is	  dominant	  in	  cTEC28,	  suggests	  that	  cTEC	  are	  capable	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of	  producing	  unique	  auto-­‐antigens	  for	  CD4	  selection.	  It	  has	  also	  been	  shown	  that	  CD80,	  
which	  provides	  essential	  signaling	  for	  formation	  of	  Treg	  precursors,	  is	  highly	  expressed	  on	  
TSCOT+	  cTEC29.	  Liston	  et	  al.	  demonstrated	  direct	  evidence	  of	  cortical	  selection	  in	  200830	  –	  
production	  of	  DP	  Foxp3+	  thymocytes	  was	  observed	  in	  mice	  where	  thymic	  MHC-­‐II	  expression	  
was	  restricted	  to	  cTEC	  –	  these	  cells	  could	  mature	  to	  become	  CD4	  SP	  upon	  purification	  and	  
were	  detected	  in	  the	  cortex	  upon	  chemokine	  signaling	  abrogation	  by	  pertussis	  toxin30.	  
Hence,	  although	  the	  thymic	  medulla	  is	  the	  main	  player	  in	  selection	  of	  Treg,	  many	  of	  the	  
factors	  required	  for	  their	  generation	  are	  common	  to	  mTEC	  and	  cTEC,	  and	  it	  seems	  likely	  that	  
both	  contribute	  to	  the	  pool	  of	  developing	  nTreg.	  
	  
2.2:	  Effector/memory	  phenotype	  Treg	  
	   There	  is	  a	  growing	  consensus	  that,	  analogous	  to	  the	  development	  of	  effector	  and	  
memory	  T	  cells	  upon	  dangerous	  antigenic	  challenge,	  Treg	  similarly	  mature	  phenotypically	  to	  
produce	  effector/memory	  cells	  with	  enhanced	  proliferative	  and	  suppressive	  capabilities.	  
Darrasse-­‐jèze	  et	  al.	  reported	  specific	  expansion	  of	  CD44hi	  Treg	  in	  the	  draining	  lymph	  nodes	  
(dLNs)	  of	  mammary	  tumours31.	  These	  Treg	  were	  antigen	  specific,	  as	  attested	  by	  models	  
expressing	  transgenic	  TCRs	  recognizing	  haemagglutinin	  (HA)	  antigen	  –	  these	  cells	  were	  only	  
expanded	  in	  dLNs	  of	  HA+	  mammary	  tumours,	  and	  tumour	  clearance	  by	  transferred	  
conventional	  effector/memory	  T	  cells	  was	  only	  effective	  early	  after	  implantation31.	  This	  was	  
recently	  elucidated	  in	  another	  model	  by	  Malchow	  et	  al.,	  who	  used	  mice	  reconstituted	  with	  a	  
low	  percentage	  of	  MJ23	  TCR	  transgenic	  bone	  marrow	  in	  addition	  to	  wildtype32.	  This	  TCR	  
recognizes	  an	  Aire-­‐dependent	  prostate	  associated	  antigen,	  and	  nTreg	  of	  this	  specificity	  were	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observed	  to	  be	  enriched	  in	  the	  dLNs	  anatomically	  associated	  with	  the	  prostate	  in	  male,	  but	  
not	  female	  (which	  lack	  the	  prostate),	  mice32.	  
	   Although	  these	  systems	  have	  shown	  the	  expansion	  and	  maintenance	  of	  antigen	  
specific	  Treg	  upon	  antigenic	  challenge,	  the	  best	  evidence	  for	  memory	  function	  analogous	  to	  
conventional	  memory	  cells	  has	  come	  through	  Rosunblum	  et	  al.’s33	  model	  of	  inducible	  OVA	  
expression	  in	  the	  skin	  under	  the	  keratin-­‐5	  promoter.	  In	  this	  system,	  OVA	  is	  constitutively	  
expressed	  in	  the	  thymus	  under	  control	  of	  Aire,	  allowing	  selection	  of	  OVA	  specific	  Treg	  from	  
DO11	  TCR	  transgenic	  cells33.	  However,	  expression	  in	  the	  skin	  is	  inducible	  through	  
administration	  of	  oral	  doxycycline,	  triggering	  T-­‐cell	  mediated	  inflammation	  of	  the	  skin,	  which	  
gradually	  self-­‐resolves	  through	  expansion	  of	  antigen-­‐specific	  Treg33.	  Upon	  second	  
administration	  of	  doxycycline,	  skin	  inflammation	  is	  either	  inapparent,	  or	  quickly	  resolves	  as	  a	  
result	  of	  small,	  but	  rapidly	  expanding	  populations	  of	  antigen	  specific	  Treg	  persisting	  in	  the	  
tissue	  itself33.	  
	   Another	  recent	  paper	  has	  implicated	  Inducible	  T-­‐cell	  Costimulator	  (ICOS)	  as	  being	  
vital	  to	  the	  expansion	  of	  antigen	  specific	  Treg.	  Tolerizing	  mucosal	  immunization	  with	  OVA	  
was	  followed	  by	  selective	  expansion	  of	  ICOS+	  Treg	  throughout	  the	  periphery,	  but	  particularly	  
in	  the	  lungs	  of	  wildtype	  mice34.	  Tolerance	  to	  challenge	  with	  OVA+LPS	  was	  achieved	  in	  
wildtype,	  but	  not	  ICOS-­‐/-­‐	  mice,	  or	  mice	  treated	  with	  ICOS	  blocking	  antibody	  prior	  to	  
tolerization,	  wherein	  airway	  hyper-­‐reactivity	  was	  observed	  as	  a	  result	  of	  failed	  accumulation	  
of	  IL-­‐10	  producing	  antigen-­‐specific	  Treg34.	  ICOS	  deficiency	  has	  also	  been	  linked	  with	  tissue	  
specific	  auto-­‐immunity	  in	  NOD	  mice,	  which	  presented	  with	  reduced	  Treg	  numbers,	  together	  
with	  extensive	  neuromuscular	  auto-­‐immunity	  upon	  it’s	  deletion35.	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   The	  central	  role	  of	  Treg	  possessing	  an	  effector	  memory	  phenotype	  -­‐	  ie.	  those	  
expressing	  ICOS	  and/or	  CD44	  -­‐	  may	  be	  explained	  by	  qualitative	  differences,	  as	  ICOS+	  Treg	  
appear	  to	  have	  superior	  proliferative	  and	  suppressive	  capabilities,	  with	  the	  ICOS-­‐	  subset	  
being	  comparatively	  death-­‐prone	  upon	  activation36.	  Differential	  cytokine	  expression	  and	  
homeostatic	  requirements	  have	  also	  been	  ascribed	  to	  ICOS+/-­‐	  subsets	  in	  humans;	  ICOS+	  Treg	  
produce	  high	  IL-­‐10,	  and	  require	  ICOSL	  on	  plasmocytoid	  DCs,	  whereas	  ICOS-­‐	  Treg	  express	  
mainly	  TGFβ	  and	  rely	  on	  CD80/86	  expression	  by	  myeloid	  DCs	  for	  survival37.	  Antigen	  
experienced	  Treg	  have	  hence	  been	  shown	  to	  possess	  unique	  functional	  capabilities,	  can	  
contribute	  to	  immunological	  memory,	  and	  are	  phenotypically	  distinct.	  
	  
2.3:	  Homeostatic	  requirements	  of	  conventional	  memory	  T	  cells	   	  
	   Conventional	  CD4	  memory	  cells	  are	  formed	  upon	  antigenic	  stimulation	  with	  
adjuvant,	  and	  are	  long-­‐lived,	  allowing	  them	  to	  rapidly	  expand	  to	  produce	  effector	  cells	  on	  
subsequent	  challenge	  with	  the	  same	  antigen.	  They	  can	  be	  subdivided	  into	  effector	  (TEM)	  and	  
central	  (TCM)	  memory	  cells	  based	  expression	  of	  CD62L38,	  with	  CD4+	  murine	  TEM	  
distinguishable	  as	  CD62L-­‐IL7RαHi	  (as	  well	  as	  CD44+CD27+),	  bearing	  receptors	  for	  entry	  into	  
inflamed	  tissues	  (CCR6)39.	  The	  homeostatic	  requirements	  for	  memory	  cells	  differ	  
considerably	  from	  conventional	  CD4s.	  TEM	  express	  high	  levels	  of	  IL7Rα,	  and	  are	  dependent	  
on	  IL-­‐7	  signaling	  for	  their	  survival40.	  IL-­‐7	  is	  also	  known	  to	  play	  a	  less	  fundamental	  role	  in	  
homeostasis	  of	  naïve	  conventional	  T	  cells	  and	  Treg41,42.	  Similarly,	  ICOS	  is	  an	  important	  co-­‐
stimulatory	  molecule	  in	  homeostasis	  of	  memory	  cells	  as	  well	  as	  expansion	  of	  antigen	  specific	  
T	  cells43.	  Importantly,	  it	  has	  also	  been	  recently	  discovered	  that	  CD4	  memory	  cells	  are	  entirely	  
dependent	  on	  signaling	  through	  another	  set	  of	  TNF	  superfamily	  members	  -­‐	  OX40	  and	  CD30	  -­‐	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expression	  of	  which	  is	  triggered	  in	  subpopulations	  of	  effector	  cells	  after	  antigenic	  challenge.	  
OX40	  expression	  is	  also	  known	  to	  be	  induced	  by	  IL-­‐7	  signaling44.	  
	   Double	  knockout	  (DKO)	  mouse	  models	  lacking	  CD30	  and	  OX40	  fail	  to	  maintain	  newly	  
generated	  effector	  cells,	  and	  DKOs	  crossed	  with	  Foxp3-­‐/-­‐	  mice	  completely	  lack	  the	  normally	  
severe	  autoimmune	  phenotype45.	  The	  ligands	  for	  CD30	  (CD30L)	  and	  OX40	  (OX40L)	  are	  up-­‐
regulated	  in	  inflammatory	  tissues,	  but	  importantly	  have	  been	  shown	  to	  be	  expressed	  by	  
lymphoid	  tissue	  inducer	  cells	  (LTi),	  as	  regulated	  in	  part	  by	  TLR-­‐2/4	  (both)46	  and	  IL7Rα	  
(OX40L)40	  signaling.	  LTi	  have	  been	  shown	  to	  play	  roles	  in	  development	  of	  lymphoid	  tissue	  
architecture,	  and	  their	  absence	  –	  as	  shown	  in	  mice	  lacking	  RORgt,	  a	  signature	  transcription	  
factor	  for	  LTi	  –	  results	  in	  the	  failure	  to	  develop	  lymph	  nodes,	  and	  incorrect	  thymic	  
architecture47.	  It	  has	  long	  been	  known	  that	  LTi	  are	  capable	  of	  interacting	  with	  primed	  
effector	  cells44,	  but	  only	  recently	  has	  it	  become	  apparent	  that	  CD4	  memory	  cell	  survival	  
relies	  entirely	  on	  receipt	  of	  CD30L/OX40L	  signals	  from	  LTi.	  This	  was	  shown	  eloquently	  by	  
Withers	  et	  al.48	  in	  a	  series	  of	  experiments,	  wherein	  mice	  lacking	  LTi	  alongside	  T	  and	  NK	  cells	  
(CD3εtg26RORgt-­‐/-­‐)	  were	  irradiated,	  and	  reconstituted	  with	  bone	  marrow	  from	  either	  
genotype	  matched,	  or	  CD3εtg26	  donors48.	  These	  mice	  were	  hence	  identical,	  with	  the	  
exception	  of	  the	  LTi	  produced	  by	  CD3εtg26	  bone	  marrow	  –	  pre-­‐made	  CD4+	  memory	  cells	  
specific	  to	  2W1S	  peptide	  were	  unable	  to	  survive	  in	  those	  mice	  lacking	  LTi,	  but	  persisted	  
normally	  in	  CD3εtg26	  reconstituted	  hosts48.	  Memory	  cells	  hence	  have	  very	  specific	  
homeostatic	  requirements,	  and	  require	  both	  soluble	  factors	  from	  stromal	  cells,	  as	  well	  as	  
TNF	  superfamily	  member	  signaling	  for	  survival.	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2.4:	  Project	  aims	  
The	  aims	  of	  this	  project	  were	  as	  follows;	  
	  
1. Analyse	  expression	  of	  Treg-­‐	  and	  activation-­‐associated	  markers	  in	  memory	  phenotype	  
Treg	  
2. Identify	  and	  compare	  the	  tissue	  locations	  of	  ICOS+/-­‐	  Treg	  sub-­‐populations	  
3. Determine	  the	  requirement	  for	  OX40	  and	  CD30	  in	  homeostasis	  of	  memory	  
phenotype	  Treg	  
4. Produce	  bone	  marrow	  chimeras	  to	  investigate	  specific	  requirements	  for	  mTEC	  
expressed	  factors	  (CD80/86	  &	  ICOSL)	  in	  development	  of	  all	  Treg	  populations	  	  
Section	  3.0:	  Methods	  
3.1:	  Animals	  
	   Wildtype	  BoyJ	  &	  C57/BL6	  mice	  were	  used	  as	  controls	  for	  Treg	  phenotyping	  of	  
C57/BL6	  background	  OX40-­‐/-­‐,	  CD30-­‐/-­‐,	  CD30-­‐/-­‐/OX40-­‐/-­‐,	  CD80/86-­‐/-­‐	  and	  ICOSL-­‐/-­‐	  mice	  in	  flow	  
cytometry	  experiments.	  	  CD45.1+	  BoyJ	  mice	  were	  used	  as	  bone	  marrow	  donors	  to	  distinguish	  
donor	  from	  host	  cells.	  All	  mice	  were	  housed	  in	  the	  BMSU	  under	  germ-­‐free	  conditions,	  aged	  
from	  6-­‐10	  weeks,	  and	  sacrificed	  using	  a	  schedule	  1	  method	  of	  killing.	  
	  
3.2:	  Media	  &	  reagents	  
	   RF10	  medium	  was	  used	  for	  disaggregating	  tissues,	  as	  well	  as	  re-­‐suspending	  cells	  in	  a	  
final	  volume	  for	  the	  purpose	  of	  counting,	  and	  consisted	  of	  RPMI	  medium	  (Sigma)	  with	  10%	  
heat-­‐inactivated	  fetal	  calf	  serum	  (FCS),	  2%	  penicillin	  and	  streptomycin,	  and	  1%	  glutamine.	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“FACS	  buffer”	  was	  used	  for	  suspension	  of	  antibody	  cocktails	  in	  staining	  for	  flow	  cytometry,	  
and	  consisted	  of	  PBS	  with	  Ca2+	  and	  Mg2+	  (Sigma)	  with	  3%	  FCS.	  Staining	  buffer	  for	  tissue	  




3.3:	  Tissue	  preparation	  for	  flow	  cytometry	  
	   Thymus,	  spleen	  and	  peripheral	  lymph	  nodes	  (PLNs;	  including	  inguinal,	  mesenteric,	  
axial,	  brachial	  and	  cervical)	  were	  isolated	  and	  cleaned	  of	  excess	  fat	  and	  connective	  tissue	  
under	  a	  light	  microscope	  using	  forceps.	  The	  cleaned	  organs	  were	  disaggregated	  between	  
two	  frosted	  microscope	  slides	  (all	  PLNs	  were	  pooled	  unless	  specified),	  and	  pipetted	  through	  
a	  fine	  gauze	  filter	  into	  a	  25ml	  falcon	  tube,	  before	  centrifugation	  (1400rpm	  for	  4	  minutes	  as	  
standard).	  Splenocytes	  were	  subjected	  to	  red	  blood	  cell	  (RBC)	  lysis	  through	  suspension	  in	  
2ml	  RBC	  lysis	  buffer	  (Sigma)	  at	  room	  temperature	  for	  5	  minutes,	  before	  neutralization	  with	  
2ml	  RF10	  and	  centrifugation.	  The	  supernatant	  was	  removed,	  and	  cells	  re-­‐suspended	  in	  a	  
known	  volume	  of	  RF10	  (5ml	  thymus	  &	  spleen,	  1ml	  lymph	  nodes),	  before	  cells	  were	  counted	  
using	  counting	  beads.	  This	  was	  done	  in	  a	  solution	  containing	  10μl	  beads	  (104	  beads),	  and	  
100μl	  cell	  solution,	  where	  cell	  numbers	  were	  calculated	  based	  on	  the	  ratio	  of	  cells:beads	  in	  a	  
plot	  of	  FSC	  vs.	  SSC.	  Cell	  suspensions	  were	  stored	  on	  ice	  at	  all	  times	  except	  where	  stated.	  	  
	  
3.4:	  Staining	  for	  flow	  cytometry	  
	   Cells	  were	  aliquoted	  into	  1.5ml	  eppendorfs	  (5x106	  cells	  for	  samples,	  2x106	  for	  single	  
colours),	  centrifuged,	  and	  supernatant	  removed.	  Single	  colour	  controls	  -­‐	  for	  compensation	  of	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samples	  through	  the	  BD	  FACS-­‐Diva	  software	  -­‐	  were	  stained	  in	  50μl,	  and	  samples	  100μl	  of	  
staining	  solution,	  which	  consisted	  of	  antibody	  cocktails	  suspended	  in	  FACS	  buffer.	  All	  
samples	  were	  re-­‐suspended	  in	  200μl	  FACS	  buffer	  in	  FACS	  tubes,	  run	  on	  the	  BD	  LSR-­‐Fortessa,	  
and	  analyzed	  using	  FlowJo	  software	  v8.7.	  Cells	  were	  spun	  down	  and	  the	  supernatant	  
removed	  prior	  to	  re-­‐suspension	  in	  the	  first	  antibody	  stain.	  All	  stains	  were	  applied	  for	  30	  
minutes	  on	  ice,	  and	  washed	  in	  1ml	  FACS	  buffer	  x1	  between	  steps,	  and	  x2	  between	  
intracellular	  stains	  and	  prior	  to	  final	  re-­‐suspension.	  	  
Treg	  phenotyping	  was	  performed	  using	  α-­‐CD4,	  CD8,	  CD25,	  CD44,	  CD69,	  TCRb,	  ICOS,	  
Neuropilin-­‐1	  (Nrp-­‐1)	  and	  Foxp3	  as	  stated	  in	  table	  1,	  where	  Nrp-­‐1	  Biotin	  was	  picked	  up	  with	  a	  
separate	  staining	  step	  using	  Streptavidin	  PeCy7	  (1:800).	  Bone	  marrow	  (BM)	  chimeras	  were	  
stained	  using	  α-­‐CD4,	  CD25,	  CD44,	  CD45.1,	  CD69,	  TCRb,	  ICOS	  and	  Nrp-­‐1	  as	  shown	  in	  table	  1.	  
Permeabilization	  and	  fixation	  of	  cells	  for	  intracellular	  staining	  was	  conducted	  using	  the	  
”Foxp3	  staining	  buffer	  kit”	  (eBioscience),	  wherein	  cells	  were	  suspended	  in	  400μl	  “Fix	  /	  Perm”	  
buffer	  (1:3	  concentrate:	  diluent)	  for	  40mins	  (refrigerated),	  and	  washed	  x2	  in	  1ml	  1:9	  “Perm	  /	  
Wash”	  buffer	  diluted	  with	  dH2O.	  Intracellular	  staining	  was	  conducted	  using	  Foxp3	  PE	  (1:100)	  
suspended	  in	  100ul	  “Perm	  /	  Wash”	  buffer	  on	  ice	  for	  30	  mins.	  
	  
3.5:	  Bone	  Marrow	  Chimeras	  
	   Cells	  for	  BM	  chimeras	  were	  prepared	  under	  a	  culture	  hood	  in	  sterile	  conditions.	  BM	  
was	  flushed	  using	  a	  needle	  filled	  with	  RF10	  from	  long-­‐bones	  of	  legs	  dissected	  from	  CD45.1+	  
BoyJ	  mice.	  Single	  cell	  solution	  was	  filtered	  and	  spun	  for	  6min	  at	  1400rpm.	  RBC	  lysis	  was	  
performed	  by	  suspension	  in	  5ml	  Gey’s	  solution	  (Sigma)	  for	  5min	  on	  ice.	  Cells	  were	  washed	  in	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10ml	  RPMI,	  and	  re-­‐suspended	  in	  15ml	  for	  counting,	  before	  centrifugation	  and	  suspension	  at	  
a	  concentration	  of	  108/ml.	  
	   T-­‐cells	  were	  depleted	  using	  magnetic	  beads;	  107	  cells	  were	  suspended	  in	  anti-­‐Thy1.2	  
biotin	  (eBioscience,	  Clone	  53-­‐2.1)	  on	  ice	  for	  30	  minutes	  and	  then	  washed	  before	  SA-­‐
conjugated	  magnetic	  beads	  were	  added	  at	  4x107/ml.	  Cells	  were	  then	  passed	  through	  a	  
magnetic	  column	  to	  remove	  T-­‐cells,	  collected	  in	  PBS	  and	  placed	  in	  orbital	  and	  rotating	  
shakers	  at	  room	  temperature	  (15min	  each),	  before	  a	  second	  passage	  down	  the	  magnetic	  
column.	  The	  supernatant	  (Thy1.2	  depleted)	  was	  stained	  for	  CD3	  and	  Thy1.2,	  and	  analysed	  by	  
FACS	  to	  confirm	  depletion,	  and	  equal	  numbers	  of	  cells	  prepared	  for	  injection	  into	  each	  
recipient	  (200μl/mouse).	  	  
	   Wildtype	  C57/BL6,	  CD80/86-­‐/-­‐	  and	  ICOSL-­‐/-­‐	  recipient	  mice	  (all	  CD45.2+)	  were	  sub-­‐
lethally	  irradiated	  with	  2x450	  rads	  after	  7	  days	  treatment	  with	  the	  antibiotic	  baytril,	  and	  
intravenously	  injected	  with	  Thy1.2-­‐depleted	  BoyJ	  BM.	  After	  6	  weeks,	  mice	  were	  drained	  of	  
serum	  by	  cardiac	  puncture	  under	  isofluorane	  anaesthetic	  without	  recovery,	  and	  thymus,	  
spleen	  and	  PLNs	  were	  dissected	  and	  prepared	  for	  flow	  cytometry	  as	  above.	  	  
	  
3.6:	  Confocal	  microscopy	  
	   Tissues	  were	  isolated	  and	  cleaned	  as	  for	  flow	  cytometry	  (above),	  before	  freezing	  in	  
OCT	  compound	  on	  aluminium	  foil	  using	  dry	  ice.	  Tissues	  were	  stored	  at	  -­‐80°c	  prior	  to	  use.	  
Tissue	  was	  sectioned	  to	  a	  width	  of	  7μm	  using	  a	  cryostat,	  and	  cut	  sections	  were	  transferred	  
to	  microscope	  slides,	  fixed	  by	  immersion	  in	  acetone	  for	  30	  mins,	  air	  dried	  (30min),	  and	  kept	  
at	  -­‐20°c	  until	  stained.	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   Staining	  was	  conducted	  using	  antibody	  cocktails	  suspended	  in	  PBS	  with	  2%	  BSA.	  
Tissue	  was	  first	  blocked	  using	  10%	  horse	  serum	  for	  15min,	  before	  pipetting	  off.	  All	  stains	  
were	  applied	  in	  75μl	  total	  volume	  per	  spot	  for	  30mins	  in	  a	  dark,	  humidified	  chamber	  at	  room	  
temperature,	  and	  then	  bathed	  in	  PBS	  for	  10	  minutes	  to	  wash.	  Primary	  stains	  were	  applied	  as	  
above;	  secondary	  and	  tertiary	  stains	  were	  incubated	  in	  1:20	  normal	  mouse	  serum	  at	  double	  
concentration	  for	  30min,	  then	  diluted	  to	  staining	  concentration	  by	  addition	  of	  PBS	  2%	  BSA,	  
to	  minimize	  non-­‐specific	  binding	  (see	  table	  2	  for	  staining	  regimes).	  After	  the	  final	  wash	  step,	  
slides	  were	  bathed	  in	  DAPI	  solution	  for	  20sec,	  and	  then	  washed	  in	  serial	  PBS	  tubes.	  Slides	  
were	  then	  removed	  of	  excess	  fluid,	  and	  placed	  on	  a	  glass	  cover	  slip	  coated	  with	  Prolong	  Gold	  
mounting	  medium,	  which	  was	  sealed	  using	  clear	  nail	  polish.	  Slides	  were	  air	  dried,	  before	  
storage	  at	  -­‐20°c.	  Imaging	  was	  performed	  with	  the	  Zeiss	  LSM	  780	  confocal	  microscope.	  
	  
3.7:	  Statistical	  analysis	  
	   Graphical	  representation	  of	  data	  and	  statistical	  analyses	  were	  accomplished	  using	  
Prism	  6	  software	  (Graphpad),	  and	  all	  p	  values	  shown	  are	  the	  results	  of	  unpaired	  t-­‐testing,	  
where	  “ns”	  =	  non-­‐significant,	  “*”	  =	  p<0.05,	  “**”	  =	  p<0.01,	  “***”	  =	  p<0.001,	  and	  “****”	  =	  
p<0.0001.	  	  
Section	  4.0:	  Results	  
4.1:	  Adult	  thymus	  and	  lymph	  nodes	  are	  home	  to	  a	  resident	  population	  Treg	  with	  a	  highly	  
activated,	  memory	  phenotype	  
	   Using	  ICOS	  and	  CD44	  as	  activation	  markers,	  we	  were	  able	  to	  identify	  distinct	  
populations	  of	  CD25+Foxp3+	  regulatory	  T	  cells	  (Treg)	  in	  the	  thymus,	  spleen	  and	  inguinal	  
	   67	  
lymph	  nodes	  (iLNs)	  of	  adult	  wildtype	  C57/BL6	  mice	  through	  flow	  cytometry.	  Although	  ICOS	  
was	  expressed	  on	  all	  thymocytes,	  in	  each	  tissue	  we	  detected	  a	  population	  low	  for	  expression	  
of	  both	  CD44	  and	  ICOS	  (ICOS/44lo/neg),	  as	  well	  as	  one	  with	  intermediate	  levels	  of	  expression	  
(ICOS/44int),	  equivalent	  to	  those	  seen	  on	  activated	  T-­‐cells	  within	  the	  CD25-­‐Foxp3-­‐	  
conventional	  subset	  (fig.	  1).	  However,	  we	  also	  observed	  a	  small	  population	  of	  CD44+	  Treg	  in	  
the	  thymus,	  and	  substantial	  numbers	  in	  the	  iLNs,	  that	  had	  very	  high	  levels	  of	  ICOS	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expression	  (ICOS/44hi)	  (fig.	  1).	  In	  the	  thymus,	  ICOS/44hi	  cells	  were	  only	  detected	  in	  the	  
CD25+Foxp3+	  population,	  amongst	  both	  CD4	  SP	  (fig.	  1)	  and	  DP	  thymocytes	  (not	  shown),	  and	  	  
not	  in	  CD25+Foxp3-­‐	  Treg	  precursors,	  and	  only	  very	  few	  conventional	  thymocytes	  with	  this	  
level	  of	  expression	  were	  present	  (fig.	  1).	  	  
	   Further	  phenotypic	  analysis	  of	  these	  3	  distinct	  ICOS/44	  expressing	  subpopulations	  
revealed	  expression	  of	  more	  markers	  typical	  of	  activated	  T	  cells,	  as	  summarized	  by	  the	  table	  
in	  figure	  3.	  With	  increasing	  expression	  of	  ICOS	  and	  CD44,	  conventional	  T	  cells	  in	  the	  thymus	  
lose	  CD69,	  and	  gain	  expression	  of	  Nrp-­‐1,	  and	  all	  ICOSint-­‐hi	  cells	  are	  CD62Lnegative	  (fig.	  2-­‐3).	  
Although	  these	  cells	  are	  likely	  a	  heterogenous	  population	  made	  up	  of;	  1.	  mature	  iNKT	  which	  
have	  lost	  CD69	  expression	  as	  seen	  in	  early	  stage	  SP	  differentiation27,	  as	  these	  are	  known	  to	  
express	  Nrp-­‐1,	  ICOS	  and	  CD44,	  and	  2.	  re-­‐circulating	  effector	  memory	  T-­‐cells	  (which	  unlike	  
central	  memory	  cells	  are	  CD62Lneg),	  as	  memory	  cells	  have	  similarly	  been	  seen	  to	  display	  
activation	  markers	  such	  as	  ICOS	  and	  CD44,	  as	  well	  as	  Nrp-­‐1,	  for	  simplicity	  these	  will	  still	  be	  
referred	  to	  as	  “conventional	  T-­‐cells”.	  	  
	   Although	  Nrp-­‐1	  is	  a	  known	  marker	  for	  all	  mature	  nTreg	  produced	  in	  the	  thymus,	  MFI	  
for	  Nrp-­‐1	  was	  lower	  in	  ICOS/44lo	  populations,	  which	  unlike	  ICOS/44int-­‐hi	  Treg	  contained	  a	  
subset	  absent	  of	  Nrp-­‐1	  expression	  (fig.	  2-­‐3).	  ICOS/44hi	  Treg	  were	  also	  slightly	  but	  
significantly	  higher	  in	  Foxp3	  expression	  (fig.	  2-­‐3).	  ICOS/44neg	  Treg	  in	  the	  thymus	  appeared	  to	  
be	  enriched	  for	  CD69	  expression	  relative	  to	  equivalent	  peripheral	  populations,	  whereas	  
CD69	  expression	  on	  ICOS/44int-­‐hi	  Treg	  was	  homogenous	  across	  all	  tissues	  –	  the	  majority	  of	  
cells	  were	  CD69+	  (fig.	  2-­‐3).	  ICOS/44neg	  Treg	  in	  all	  tissues	  expressed	  the	  naïve	  T-­‐cell	  marker	  
CD62L	  (fig.	  2-­‐3),	  which	  is	  required	  for	  entry	  into	  secondary	  lymphoid	  tissues,	  including	  the	  
LNs	  and	  spleen.	  However,	  expression	  of	  this	  marker	  was	  lost	  upon	  up-­‐regulation	  of	  ICOS	  and	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CD44	  expression	  –	  few	  CD62L+	  cells	  were	  detected	  among	  ICOS/44int,	  and	  no	  CD62L+	  cells	  
were	  present	  in	  ICOS/44hi	  populations	  (fig.	  2-­‐3).	  Treg	  express	  lower	  IL-­‐7Rα	  than	  conventional	  
T-­‐cells	  –	  IL-­‐7	  has	  been	  shown	  to	  play	  a	  role	  in	  homeostasis	  of	  naïve	  and	  memory	  T-­‐cells,	  but	  
has	  relatively	  minor	  function	  in	  Treg.	  Our	  data	  shows	  that	  IL-­‐7Rα	  is	  significantly	  up-­‐regulated	  
by	  ICOS/44hi	  Treg	  in	  the	  thymus	  and	  iLNs,	  but	  not	  Treg	  in	  the	  spleen,	  nor	  ICOS/44	  expressing	  
conventional	  cells,	  which	  express	  the	  same,	  if	  not	  slightly	  reduced	  levels	  than	  ICOS/44neg	  
cells	  (fig.	  2-­‐3).	  
	  
4.2:	  ICOS	  expressing	  Treg	  are	  spread	  through	  the	  thymic	  medulla,	  and	  iLNs	  
	   Using	  confocal	  microscopy,	  it	  was	  possible	  to	  stain	  for	  ICOS	  and	  Foxp3	  to	  distinguish	  
ICOS+	  and	  ICOS-­‐	  Treg	  (although	  levels	  of	  expression	  could	  not	  be	  defined)	  in	  both	  the	  thymus	  
and	  the	  iLNs.	  ICOS	  is	  also	  expressed	  on	  CD3-­‐4+	  lymphoid	  tissue	  inducer	  cells	  (LTi),	  and	  hence	  
CD3	  staining	  was	  used	  in	  the	  thymus	  to	  detect	  conventional	  thymocytes	  expressing	  ICOS.	  
ICOS+	  and	  ICOS-­‐	  Treg	  were	  indistinguishable	  by	  location	  in	  both	  tissues;	  they	  were	  present	  in	  
both	  the	  T	  zones	  and	  follicles	  of	  the	  iLNs	  (fig.	  4),	  and	  were	  only	  observed	  in	  the	  thymic	  
medulla	  (fig.	  5),	  as	  marked	  by	  the	  presence	  of	  ER-­‐TR5+	  mTECs.	  ICOS	  expressing	  cells	  as	  a	  
whole	  were	  only	  observed	  in	  the	  medulla	  of	  the	  thymus	  (fig.	  5),	  in	  keeping	  with	  the	  idea	  that	  
a	  substantial	  proportion	  are	  iNKT,	  as	  the	  majority	  of	  thymic	  resident	  iNKT	  are	  thought	  to	  be	  
retained	  in	  this	  location49.	  	  
	   Consistent	  with	  the	  FACS	  data,	  ICOS+	  Treg	  were	  present	  in	  much	  greater	  abundance	  
in	  the	  iLNs	  (fig.	  4).	  The	  two	  thymic	  ICOS+	  Treg	  that	  were	  observed	  were	  located	  close	  to	  the	  
cortico-­‐medullary	  junction	  (fig.	  5),	  and	  it	  is	  tempting	  to	  suggest	  that	  this	  is	  their	  specific	  
place	  of	  residence	  in	  the	  medulla,	  however	  much	  more	  data	  is	  required	  for	  quantification	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and	  confirmation	  of	  this	  theory.	  Similarly,	  one	  of	  the	  ICOS+	  Treg	  observed	  appears	  to	  be	  in	  
close	  proximity	  with	  a	  CD3-­‐4+ICOS+	  cell	  (fig.	  5),	  but	  it	  is	  not	  possible	  to	  determine	  whether	  
this	  is	  genuine	  interaction,	  or	  just	  co-­‐incidental	  positioning	  without	  quantification.	  In	  the	  
iLNs,	  neither	  ICOS+/-­‐	  Treg	  were	  enriched	  at	  the	  marginal	  sinus,	  nor	  inter-­‐follicular	  spaces	  
associated	  with	  LTi	  (fig.	  4).	  	  
	  
4.3:	  ICOS/44high	  Treg	  do	  not	  share	  homeostatic	  requirements	  of	  memory	  T	  cells	  
	   Given	  the	  shared	  phenotype	  of	  ICOS/44hi	  Treg	  and	  memory	  cells,	  we	  were	  curious	  to	  
see	  if	  they	  similarly	  shared	  requirements	  for	  homeostasis	  and	  survival.	  CD4+	  memory	  cells	  
are	  known	  to	  depend	  on	  OX40L	  and	  CD30L	  as	  survival	  signals	  provided	  by	  LTi	  in	  secondary	  
lymphoid	  organs	  after	  induction	  by	  antigenic	  challenge.	  Using	  CD30-­‐/-­‐,	  OX40-­‐/-­‐	  and	  
CD30/OX40	  double	  knockout	  (DKO)	  mice,	  we	  aimed	  to	  determine	  whether	  the	  same	  was	  
true	  of	  our	  memory	  phenotype	  Treg.	  Firstly,	  flow	  cytometry	  was	  used	  to	  determine	  the	  
expression	  of	  OX40	  on	  Treg	  (fig.	  6).	  We	  found	  OX40	  to	  be	  expressed	  on	  some	  Treg	  right	  from	  
the	  CD25+Foxp3-­‐	  precursor	  stage,	  with	  the	  majority	  of	  thymic	  (88.7%)	  and	  splenic	  (66.8%)	  
Treg	  expressing	  OX40	  (fig.	  6).	  By	  contrast,	  only	  a	  minority	  (13.4%)	  of	  SP	  CD4s	  were	  OX40+,	  
with	  even	  fewer	  in	  the	  spleen	  (1.71%)	  (fig.	  6).	  
	   As	  evaluated	  by	  FACS,	  there	  was	  around	  a	  50%	  reduction	  in	  both	  the	  proportion	  and	  
number	  of	  Treg	  in	  the	  thymus	  of	  OX40-­‐/-­‐	  and	  DKO	  mice;	  however	  there	  was	  no	  reduction	  in	  
precursor	  numbers	  in	  any	  of	  the	  KOs	  modeled	  (fig.	  7a).	  There	  was	  also	  a	  significant	  increase	  
in	  the	  proportion	  of	  Treg	  amongst	  CD4	  SP	  cells	  in	  the	  CD30-­‐/-­‐	  thymus,	  although	  no	  increase	  in	  
absolute	  numbers	  of	  Treg	  (fig.	  7a).	  Both	  ICOS/44+	  Treg	  populations	  were	  reduced	  (fig.	  7a),	  
but	  there	  did	  not	  appear	  to	  be	  a	  specific	  loss	  of	  ICOS/44+	  effector	  /	  memory	  Treg	  as	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observed	  in	  our	  pilot	  experiments	  for	  the	  CD80/86-­‐/-­‐	  (not	  shown).	  A	  different	  story	  emerged	  
in	  the	  spleen;	  Treg	  were	  depleted,	  but	  only	  in	  the	  DKO,	  and	  not	  the	  OX40-­‐/-­‐	  -­‐	  this	  again	  was	  
not	  restricted	  to	  one	  ICOS/44	  phenotype	  (fig.	  7b).	  Treg	  were	  also	  proportionally	  lowered	  in	  
the	  iLNs	  of	  OX40-­‐/-­‐	  and	  DKO	  mice,	  however	  this	  may	  be	  accounted	  for	  by	  dilution	  caused	  by	  
swelling	  of	  the	  lymph	  nodes,	  as	  absolute	  cell	  numbers	  were	  seen	  to	  be	  raised	  (fig.	  7c).	  This	  
effect	  was	  observed	  consistently	  in	  these	  KO	  models,	  and	  could	  imply	  expansion	  as	  a	  result	  
of	  autoimmune	  responses.	  	  
	  
4.4:	  ICOSL	  and	  CD80/86	  are	  not	  required	  on	  mTEC	  for	  Treg	  selection	  
	   A	  wealth	  of	  data	  exists	  on	  the	  reliance	  on	  CD80/86	  co-­‐stimulation	  for	  generation	  of	  
nTreg,	  and	  CD80/86	  expression	  appears	  to	  be	  required	  for	  both	  selection	  of	  CD25+	  
progenitors23,20,19,	  as	  well	  as	  maintenance	  of	  mature	  Foxp3+	  cells	  in	  the	  thymus	  and	  
periphery18.	  Indeed,	  our	  pilot	  experiment,	  and	  work	  by	  others	  in	  the	  lab	  have	  demonstrated	  
a	  reduction	  in	  all	  Treg	  subpopulations	  in	  CD80/86-­‐/-­‐	  mice,	  with	  a	  specific	  loss	  of	  ICOS/44+	  
cells	  -­‐	  large	  numbers	  of	  ICOS/44int	  were	  lost,	  and	  ICOS/44hi	  cells	  were	  notably	  absent	  (not	  
shown).	  However,	  to	  our	  knowledge,	  no	  studies	  have	  currently	  determined	  whether	  
CD80/86	  expression	  is	  specifically	  required	  on	  thymic	  epithelial	  cells.	  ICOSL	  is	  another	  
important	  immune	  co-­‐stimulatory	  molecule	  expressed	  on	  mTEC,	  although	  a	  role	  in	  
development	  of	  conventional	  thymocytes	  and	  Treg	  has	  yet	  to	  be	  established.	  	  
	   In	  order	  to	  investigate	  the	  requirement	  for	  CD80/86	  and	  ICOSL	  expression	  on	  thymic	  
stroma	  for	  selection	  of	  nTreg,	  we	  created	  bone	  marrow	  chimeras	  using	  wildtype	  CD45.1+	  
donor	  bone	  marrow	  transferred	  to	  an	  irradiated	  CD45.1-­‐	  host.	  Hosts	  were	  CD45.1-­‐	  wildtype,	  
CD80/86-­‐/-­‐	  and	  ICOSL-­‐/-­‐	  mice,	  and	  Treg	  populations,	  split	  into	  donor	  (chimeric,	  CD45.1+)	  and	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host	  (CD45.1-­‐)	  cells,	  were	  analyzed	  by	  FACS	  (fig.	  8).	  Repopulation	  of	  the	  thymus	  appeared	  to	  
occur	  more	  efficiently	  in	  the	  ICOSL-­‐/-­‐	  hosts,	  where	  even	  host-­‐derived	  thymocyte	  numbers	  
were	  raised	  (fig.	  9),	  providing	  difficulty	  in	  comparing	  populations	  numerically,	  as	  all	  ICOSL-­‐/-­‐	  
host	  T-­‐cell	  populations	  were	  numerically	  raised	  relative	  to	  wildtype	  (fig.	  9-­‐10).	  The	  
proportion	  of	  our	  control	  population	  –	  CD4+8-­‐TCRhi	  cells	  –	  was	  also	  significantly	  higher	  
among	  donor-­‐derived	  cells	  in	  the	  ICOSL-­‐/-­‐	  thymus	  and	  spleen,	  as	  well	  as	  host-­‐derived	  
thymocytes	  (fig.	  9).	  
	   It	  was	  however	  still	  clear	  from	  our	  findings	  that	  there	  was	  no	  fault	  in	  thymic	  
production	  of	  Treg	  of	  any	  phenotype	  from	  donor	  cells	  in	  either	  KO	  chimera	  –	  CD25+	  
precursors	  and	  Treg	  were	  present	  at	  proportions	  (fig.	  10)	  and	  in	  numbers	  (fig.	  11)	  either	  
comparable	  to	  or	  greater	  than	  those	  in	  the	  wildtype	  thymus.	  These	  findings	  were	  matched	  in	  
the	  spleen	  (ICOSL-­‐/-­‐	  and	  CD80/86-­‐/-­‐,	  fig.	  12)	  and	  PLNs	  (CD80/86-­‐/-­‐,	  fig.	  13)	  -­‐	  although	  splenic	  
Treg	  were	  significantly	  reduced	  as	  a	  proportion	  in	  the	  CD80/86-­‐/-­‐,	  the	  percentage	  change	  
was	  only	  very	  slight.	  ICOS/44int-­‐hi	  Treg,	  which	  we	  observed	  to	  be	  largely	  absent	  in	  the	  
CD80/86-­‐/-­‐	  mouse	  (not	  shown)	  were	  similarly	  present	  in	  equivalent	  or	  higher	  numbers	  and	  
percentages	  than	  wildtype	  hosts	  in	  the	  donor-­‐derived	  Treg	  of	  both	  CD80/86-­‐/-­‐	  and	  ICOSL-­‐/-­‐	  
chimeras	  (figs.	  10-­‐13).	  Interestingly,	  normal	  Treg	  proportions,	  complete	  with	  the	  ICOS/44+	  
populations	  were	  also	  present	  among	  the	  host	  T-­‐cells	  of	  CD80/86-­‐/-­‐	  mice	  (fig.	  11-­‐13),	  
suggesting	  wildtype	  donor	  bone	  marrow	  has	  a	  restorative	  effect	  on	  both	  generation	  and	  
homeostasis	  of	  CD80/86-­‐/-­‐	  T-­‐cells.	  
	   An	  overwhelming	  majority	  of	  CD45.1-­‐	  host	  cells	  expressed	  ICOS	  and	  CD44	  in	  all	  
tissues	  of	  the	  bone	  marrow	  chimeras.	  DP	  thymocytes,	  which	  would	  represent	  a	  CD4+TCRlow	  
population,	  were	  absent	  from	  host	  cells	  in	  each	  instance	  (fig.	  8a	  “*”),	  suggesting	  that	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ablation	  of	  host	  bone	  marrow	  was	  complete	  upon	  irradiation,	  and	  the	  host	  cells	  remaining	  
are	  radio-­‐resistant	  rather	  than	  newly	  generated.	  This	  is	  supported	  by	  the	  absence	  of	  CD25+	  
Treg	  precursors	  (fig.	  10)	  	  –	  although	  these	  did	  appear	  to	  be	  present	  in	  the	  ICOSL-­‐/-­‐	  thymus	  
(fig.	  10),	  this	  can	  likely	  be	  attributed	  to	  stress-­‐induced	  activation	  of	  conventional	  cells,	  which	  
up-­‐regulate	  CD25,	  as	  there	  was	  a	  delay	  of	  24hrs	  between	  harvesting	  and	  staining.	  CD45.1-­‐	  
host-­‐derived	  conventional	  cells	  were	  overwhelmingly	  of	  the	  ICOS/44int	  phenotype	  (figs.	  10-­‐
13),	  whereas	  Treg	  were	  split	  evenly	  between	  ICOS/44int	  and	  ICOS/44hi	  populations	  (figs.	  10-­‐
13).	  Among	  donor-­‐derived	  cells,	  significantly	  higher	  proportions	  of	  ICOS/44int	  Treg	  were	  
observed	  in	  the	  ICOSL-­‐/-­‐	  (fig.	  10-­‐11),	  although	  this	  could	  be	  the	  result	  of	  receptor	  up-­‐
regulation	  in	  the	  face	  of	  ligand	  deletion.	  	  
	   Lastly,	  we	  observed	  notable	  reductions	  or	  total	  absence	  of	  the	  small	  numbers	  of	  
host-­‐	  and	  donor-­‐derived	  ICOS/44hi	  conventional	  cells	  in	  the	  spleen	  and	  PLNs	  of	  CD80/86-­‐/-­‐	  
hosts	  (figs.	  12-­‐13).	  CD80/86	  is	  known	  to	  be	  an	  important	  factor	  in	  development	  of	  iNKT50	  
and	  memory	  cells51,	  both	  of	  which	  express	  ICOS	  and	  CD44.	  Our	  pilot	  study	  showed	  a	  similar	  
reduction	  in	  conventional	  ICOS/44int	  cells	  (not	  shown),	  and	  we	  observed	  a	  loss	  of	  iNKT	  
numbers	  in	  the	  thymus,	  but	  not	  spleen	  and	  iLNs	  (not	  shown),	  although	  these	  numbers	  were	  
not	  sufficient	  to	  explain	  the	  loss	  of	  ICOS/44int	  cells.	  Hence	  the	  results	  from	  the	  bone	  marrow	  
chimera	  show	  either	  a	  likely	  persisting	  defect	  in	  the	  formation	  of	  iNKT	  and/or	  memory	  cells	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Section	  5.0:	  Discussion	  
5.1:	  Co-­‐stimulatory	  requirements	  for	  Treg	  generation	  
	   Treg	  possessing	  a	  highly	  activated	  phenotype,	  including	  expression	  of	  the	  markers	  
ICOS	  and	  CD44,	  have	  previously	  been	  demonstrated	  to	  be	  antigen-­‐specific	  effector	  /	  
memory	  populations32,31.	  In	  preliminary	  experiments,	  we	  have	  observed	  these	  cells	  to	  have	  a	  
specific	  dependence	  on	  co-­‐stimulation	  by	  the	  CD28	  ligands	  CD80	  and	  CD86	  -­‐	  ICOS/44	  
expressing	  Treg	  were	  absent	  in	  CD80/86-­‐/-­‐	  mice,	  although	  a	  total	  reduction	  in	  Treg	  numbers	  
was	  not	  exclusive	  to	  this	  subset	  (data	  not	  shown).	  Studies	  have	  suggested	  multiple	  factors	  
contribute	  to	  the	  loss	  of	  Treg	  in	  these	  mice,	  including	  failure	  in	  initial	  selection,	  as	  few	  CD25+	  
precursors	  are	  present20,22,52,	  as	  well	  as	  reduced	  conventional	  T-­‐cell	  production	  of	  the	  Treg	  
trophic	  factor	  IL-­‐2,	  which	  is	  required	  for	  homeostatic	  proliferation	  of	  mature	  
populations18,23,41.	  We	  observed	  normal	  Treg	  populations	  to	  be	  restored	  in	  mice	  when	  the	  
deletion	  of	  CD80/86	  was	  restricted	  to	  the	  stromal	  cell	  compartment	  through	  reconstitution	  
with	  wildtype	  bone	  marrow	  (BM).	  	  
	   That	  equivalent	  numbers	  of	  CD25+	  precursors	  were	  detected	  in	  the	  thymi	  of	  both	  
WTèWT	  	  and	  WTèCD80/86-­‐/-­‐	  mice	  suggests	  that	  selection	  of	  Treg	  -­‐	  requiring	  strong	  TCR	  
ligation	  together	  with	  CD80/86	  co-­‐stimulation	  -­‐	  was	  normal.	  As	  this	  process	  has	  been	  shown	  
to	  be	  largely	  mediated	  by	  both	  mTEC	  and	  medullary	  DCs14,	  this	  finding	  suggests	  that	  mTEC	  
selection	  is	  either	  redundant	  in	  the	  presence	  of	  wildtype	  DCs,	  or	  relies	  on	  alternative	  co-­‐
stimulatory	  pathways.	  However,	  it	  is	  difficult	  to	  be	  certain	  that	  mTEC	  CD80/86	  expression	  is	  
redundant	  physiologically,	  as	  the	  cellularity	  of	  the	  thymus	  in	  our	  BM	  chimeras	  was	  greatly	  
reduced,	  and	  TCR	  transgenic	  models	  have	  shown	  the	  selective	  niche	  for	  Treg	  precursors	  to	  
be	  limited53.	  Hence,	  if	  more	  thymocytes	  were	  present,	  the	  absence	  of	  selecting	  mTECs	  could	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prove	  to	  be	  a	  limiting	  factor,	  reducing	  nTreg	  generation.	  That	  Foxp3+	  DP	  cells	  were	  similarly	  
present	  in	  normal	  numbers	  in	  our	  CD80/86-­‐/-­‐	  host	  BM	  chimeras	  (data	  not	  shown)	  suggests	  
that	  cortical	  DCs	  are	  likely	  sufficient	  for	  their	  selection.	  Redundancy	  of	  DC	  expression	  of	  
CD80/86	  with	  respect	  to	  mTECs	  could	  be	  elucidated	  using	  a	  conditional	  knockout	  model,	  
wherein	  the	  gene	  for	  CD80	  or	  CD86	  is	  flanked	  by	  Lox-­‐P	  sites,	  and	  can	  be	  excised	  on	  
expression	  of	  CRE-­‐recombinase	  under	  control	  of	  the	  DC-­‐specific	  promoter	  for	  CD11c.	  
	   Importantly,	  ICOS/44int-­‐hi	  Treg	  were	  also	  found	  among	  CD45.1-­‐	  host	  cells	  of	  CD80/86-­‐/-­‐	  
BM	  chimeras.	  As	  thymic	  host	  precursors	  were	  not	  present,	  and	  ICOS/44+	  cells	  were	  mostly	  
absent	  in	  the	  CD80/86-­‐/-­‐,	  it	  appears	  that	  ICOS/44+	  populations	  can	  be	  formed	  from	  ICOS/44-­‐	  
in	  an	  environment	  sufficient	  for	  CD80/86.	  ICOS/44hi	  conventional	  cells	  were,	  however,	  
conspicuously	  absent	  from	  the	  spleen	  and	  PLNs	  of	  WTèCD80/86-­‐/-­‐	  BM	  chimeras.	  Our	  
preliminary	  experiments	  confirmed	  a	  reduction	  in	  conventional	  ICOS/44+	  cells	  in	  CD80/86-­‐/-­‐	  
mice,	  some	  of	  which	  were	  explained	  by	  reduced	  thymic	  output	  of	  iNKT	  (data	  not	  shown).	  It	  
is	  therefore	  possible	  that	  this	  defect	  in	  thymic	  iNKT	  production	  is	  to	  some	  degree	  still	  
present,	  even	  after	  reconstitution	  with	  wildtype	  BM.	  
	   Our	  phenotyping	  of	  the	  thymic	  ICOS/44hi	  Treg	  population	  suggests	  maturity;	  they	  
uniformly	  express	  high	  levels	  of	  both	  Foxp3	  and	  Nrp-­‐1,	  and	  have	  lost	  expression	  of	  the	  naïve	  
T	  cell	  marker	  CD62L.	  This	  is	  consistent	  with	  the	  idea	  that	  ICOS+	  and	  CD44+	  Treg	  constitute	  an	  
effector	  /	  memory	  population,	  arising	  from	  naïve	  precursors	  upon	  peripheral	  antigen	  
encounter31,32,41.	  This	  is	  supported	  from	  the	  opposite	  perspective	  by	  the	  enrichment	  of	  
CD69+	  cells	  among	  thymic	  ICOS/44neg	  Treg	  relative	  to	  the	  periphery.	  In	  the	  thymus	  CD69	  is	  a	  
marker	  for	  immature	  SP	  populations,	  and	  is	  expressed	  immediately	  following	  positive	  
selection,	  then	  down-­‐regulated	  prior	  to	  emigration27	  –	  however,	  peripheral	  T-­‐cells	  express	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CD69	  upon	  activation54.	  These	  patterns	  of	  expression	  are	  hence	  consistent	  with	  Treg	  
maturing	  as	  ICOS/44neg	  cells	  before	  exiting	  to	  the	  periphery,	  then	  up-­‐regulating	  ICOS	  and	  
CD44	  upon	  antigen	  encounter,	  and	  re-­‐circulating	  to	  the	  thymus.	  	  
	   RAG-­‐GFP	  mice	  have	  revealed	  that	  up	  to	  60%	  of	  thymic	  Treg	  represent	  an	  older,	  either	  
re-­‐circulating	  or	  resident	  population	  (GFP-­‐),	  rather	  than	  those	  recently	  generated	  within	  the	  
thymus	  (GFP+)23.	  The	  mature	  phenotype	  of	  ICOS/44+	  Treg	  suggests	  that	  they	  represent	  a	  
significant	  proportion	  of,	  although	  not	  all,	  thymic	  GFP-­‐	  Treg.	  Although	  this	  system	  cannot	  
differentiate	  between	  cells	  that	  undergo	  prolonged	  thymic	  retention	  after	  generation,	  and	  
those	  that	  are	  re-­‐circulating	  from	  the	  periphery,	  it	  would	  prove	  useful	  in	  confirming	  the	  
maturity	  of	  ICOS/44+	  Treg.	  Interestingly,	  a	  recent	  study	  on	  RAG-­‐GFP	  mice	  deficient	  in	  CD40	  
or	  CD80/86	  has	  shown	  the	  GFP-­‐	  subset	  to	  be	  particularly	  susceptible	  to	  a	  loss	  of	  IL-­‐2	  relative	  
to	  GFP+	  cells	  and	  precursors23.	  It	  was	  suggested	  that	  the	  cause	  of	  thymic	  Treg	  loss	  in	  CD40-­‐/-­‐	  
mice	  was	  down	  to	  failure	  in	  homeostasis	  of	  GFP-­‐	  cells,	  with	  no	  observable	  defect	  in	  thymic	  
generation23.	  Although	  this	  paper	  found	  equivalent	  defects	  in	  both	  GFP+/-­‐	  Treg	  subsets	  in	  
CD80/86-­‐/-­‐	  thymi23,	  as	  the	  GFP-­‐	  subset	  is	  too	  large	  to	  consist	  solely	  of	  ICOS/44+	  cells,	  the	  loss	  
of	  ICOS/44+	  Treg	  from	  the	  GFP-­‐	  subset	  may	  have	  been	  diluted	  by	  the	  inclusion	  of	  GFP-­‐	  
ICOS/44-­‐	  Treg,	  which	  are	  relatively	  retained.	  In	  any	  case,	  it	  would	  be	  useful	  to	  introduce	  
exogenous	  IL-­‐2:α-­‐IL-­‐2	  conjugates	  to	  observe	  whether	  the	  proportion	  of	  ICOS/44+	  cells	  is	  
restored	  in	  CD80/86-­‐/-­‐	  mice,	  and	  confirming	  selective	  sensitivity	  to	  IL-­‐2	  depletion.	  If	  this	  were	  
the	  case,	  the	  loss	  of	  ICOS/44+	  Treg	  would	  likely	  be	  the	  result	  of	  disrupted	  homeostasis	  of	  a	  
precursor	  population,	  rather	  than	  ICOS/44hi	  Treg	  themselves,	  as	  these	  cells	  likely	  depend	  on	  
IL-­‐7	  for	  turnover41.	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   That	  ICOS/44+	  Treg	  in	  the	  thymus	  can	  simply	  be	  explained	  as	  recirculating	  antigen-­‐
experienced	  cells	  is	  complicated	  by	  our	  observation	  of	  ICOS/44hi	  cells	  among	  TCRhi	  DP	  Foxp3+	  
thymocytes	  (data	  not	  shown).	  Our	  pilot	  experiment	  shows	  that	  these	  are	  again	  lost	  in	  
CD80/86-­‐/-­‐	  mice,	  suggesting	  either	  that	  ICOS/44hi	  Treg	  can	  be	  generated	  within	  the	  thymus	  
as	  a	  phenotypically	  unique	  subset,	  or	  instead	  ICOS	  and	  CD44	  are	  transiently	  up-­‐regulated	  on	  
some,	  if	  not	  all	  developing	  Treg	  (although	  the	  latter	  seems	  unlikely	  due	  to	  the	  mature	  
phenotype	  of	  ICOS/44hi	  Treg).	  Initial	  phenotyping	  of	  7-­‐day	  old	  newborn	  mice	  suggests	  that	  
ICOS/44hi	  Treg	  are	  not	  present	  at	  this	  early	  stage,	  although	  some	  cells	  were	  ICOS/44int	  (data	  
not	  shown).	  Given	  the	  delayed	  appearance	  of	  Treg	  in	  the	  newborn	  thymus,	  which	  coincides	  
with	  medullary	  development26,	  it	  seems	  plausible	  that	  extended	  maturation	  of	  the	  thymic	  
micro-­‐environment	  is	  required	  for	  generation	  of	  ICOS/44hi	  Treg.	  Several	  approaches	  would	  
be	  effective	  for	  determining	  the	  ontogeny	  of	  ICOS/44hi	  Treg;	  Treg	  could	  be	  phenotyped	  in	  
mice	  of	  increasing	  age	  to	  determine	  the	  first	  point	  of	  emergence,	  the	  development	  of	  sorted	  
ICOS/44+/-­‐	  Treg	  could	  be	  tracked	  on	  introduction	  into	  fetal	  thymic	  organ	  cultures	  (FTOC)55,	  or	  
Treg	  could	  be	  selectively	  deleted	  in	  RAG-­‐GFP	  mice	  using	  α-­‐CD25	  antibodies4,	  and	  re-­‐
population	  of	  GFP+	  Treg	  examined.	  
	   No	  defects	  in	  Treg	  generation	  or	  homeostasis	  were	  observed	  in	  either	  pilot	  
experiments	  involving	  ICOSL-­‐/-­‐	  mice	  (data	  not	  shown),	  or	  WTèICOSL-­‐/-­‐	  BM	  chimeras.	  This	  is	  
surprising,	  as	  previous	  reports	  suggest	  that	  ICOS	  signaling	  is	  crucial	  in	  the	  maintenance	  of	  
effector	  /	  memory	  Treg34,56,	  although	  these	  studies	  were	  performed	  in	  the	  context	  of	  the	  
immune	  response	  to	  allo-­‐antigen	  challenge,	  and	  may	  not	  represent	  the	  homeostatic	  
requirements	  of	  these	  cells.	  Currently,	  no	  role	  has	  been	  ascribed	  to	  mTEC	  expression	  of	  
ICOSL57.	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5.2:	  Homeostatic	  requirements	  of	  TEM	  and	  memory	  Treg	  are	  not	  shared	  
	   Having	  analyzed	  Treg	  populations	  by	  FACS	  in	  a	  variety	  of	  primary	  and	  secondary	  
lymphoid	  organs,	  we	  detected	  ICOS/44neg-­‐lo	  Treg	  in	  each	  of	  the	  thymus,	  spleen,	  BM,	  and	  all	  
PLNs,	  but	  ICOS/44hi	  Treg	  were	  markedly	  absent	  from	  the	  spleen	  and	  BM,	  and	  significantly	  
reduced	  in	  the	  mesenteric	  lymph	  nodes	  (mLN)	  relative	  to	  other	  PLNs	  (PLNs	  and	  BM	  not	  
shown).	  This	  is	  a	  curious	  finding,	  as	  the	  spleen,	  and	  particularly	  the	  bone	  marrow	  are	  known	  
to	  provide	  IL-­‐7	  to	  support	  homeostasis	  of	  resident	  memory	  cell	  populations58,59,	  and	  
ICOS/44hi	  Treg	  have	  up-­‐regulated	  IL-­‐7Rα	  expression,	  likely	  sharing	  this	  requirement	  for	  IL-­‐
741.	  The	  reduced	  representation	  in	  the	  MLNs	  may	  imply	  that	  ICOS/44hi	  cells	  are	  solely	  nTreg,	  
as	  iTreg	  are	  enriched	  in	  the	  MLN	  through	  induction	  in	  response	  to	  food	  and	  microbiotal	  
antigens	  in	  the	  gut60.	  Antigen	  expression	  may	  instead	  dictate	  the	  location	  of	  ICOS/44hi	  Treg,	  
as	  they	  are	  specifically	  enriched	  at	  lymph	  nodes	  draining	  the	  tissues,	  and	  in	  the	  thymus,	  
where	  TSAs	  are	  promiscuously	  expressed.	  	  
	   As	  conventional	  memory	  cells,	  iNKT	  and	  Treg	  are	  known	  to	  be	  relatively	  radio-­‐
resistant	  populations5,61,	  the	  CD45.1-­‐	  host	  cells	  of	  our	  BM	  chimeras	  presented	  a	  unique	  
opportunity	  to	  observe	  the	  phenotype	  of	  these	  cells	  in	  isolation.	  Conventional	  T-­‐cells	  were	  
seen	  to	  possess	  an	  ICOS/44int	  phenotype,	  suggesting	  we’re	  correct	  in	  our	  assumption	  that	  
these	  represent	  TEM	  and	  iNKT	  in	  the	  wildtype.	  Because	  ICOS/44int	  Treg	  appear	  to	  share	  both	  
a	  phenotype,	  and	  tissue	  distribution	  with	  conventional	  CD4	  memory	  cells,	  it	  is	  tempting	  to	  
assume	  that	  they	  possess	  the	  same	  homeostatic	  requirements,	  including	  the	  provision	  of	  
OX40L	  and	  CD30L	  by	  LTi44,48.	  A	  shared	  dependence	  on	  IL-­‐7	  seems	  unlikely,	  as	  ICOS/44int	  Treg	  
fail	  to	  up-­‐regulate	  IL-­‐7Rα,	  but	  this	  could	  easily	  be	  confirmed	  in	  a	  survival	  assay	  wherein	  Treg	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are	  transferred	  to	  an	  IL-­‐7-­‐/-­‐	  host.	  Staining	  of	  ICOS+	  Treg	  in	  sections	  of	  iLN	  for	  confocal	  analysis	  
demonstrated	  localization	  indistinguishable	  from	  their	  ICOS-­‐	  counterparts,	  with	  no	  sign	  of	  
enrichment	  at	  sites	  associated	  with	  LTi48.	  ICOS+	  cells	  in	  the	  thymus	  were	  restricted	  to	  the	  
medulla,	  as	  were	  Treg,	  but	  although	  we	  only	  observed	  two	  ICOS+	  Treg,	  they	  were	  both	  
located	  at	  the	  cortico-­‐medullary	  junction,	  suggesting	  these	  cells	  are	  re-­‐circulating	  from	  the	  
periphery,	  and	  one	  was	  caught	  in	  interaction	  with	  an	  ICOS+CD3-­‐CD4+	  cell	  –	  a	  phenotype	  
associated	  with	  LTi,	  although	  the	  markers	  RORgt	  and	  IL-­‐7Rα	  would	  be	  required	  for	  
confirmation.	  
	   We	  detected	  ICOS/44+	  Treg	  in	  a	  RORgt-­‐/-­‐	  pilot	  experiment	  (not	  shown),	  but	  ICOS/44+	  
conventional	  cells	  in	  these	  mice	  do	  not	  possess	  genuine	  memory	  function	  –	  to	  better	  
evaluated	  the	  dependence	  of	  these	  cells	  on	  LTi,	  we	  utilized	  mice	  deleted	  of	  OX40	  and/or	  
CD30.	  CD30-­‐/-­‐	  Treg	  seemed	  phenotypically	  normal,	  were	  present	  in	  normal	  numbers,	  and	  
were	  if	  anything	  proportionally	  raised	  in	  the	  thymus.	  We	  detected	  expression	  of	  OX40	  on	  
Treg	  right	  from	  the	  precursor	  stage	  –	  expression	  was	  highest	  in	  thymic	  Treg,	  but	  the	  majority	  
of	  thymic	  and	  splenic	  Treg	  were	  OX40+,	  unlike	  conventional	  T	  cells,	  which	  were	  almost	  
entirely	  OX40-­‐.	  When	  OX40	  was	  deleted,	  thymic	  Treg	  were	  significantly	  reduced	  –	  surprising,	  
as	  OX40	  ligation	  has	  previously	  been	  shown	  to	  down-­‐regulate	  Foxp3	  expression62	  -­‐	  although	  
precursors	  were	  present	  in	  normal	  proportions.	  Treg	  in	  the	  spleen	  were	  reduced	  significantly	  
to	  a	  lesser	  extent,	  but	  only	  in	  the	  OX40/CD30	  DKO.	  This	  suggests	  that	  OX40	  plays	  an	  
important	  role	  after	  initial	  selection	  in	  thymic	  generation	  of	  Treg,	  which	  can	  be	  made	  up	  in	  
the	  periphery,	  presumably	  by	  expansion	  of	  existing	  populations,	  except	  in	  DKO	  mice.	  OX40	  
and	  CD30	  may	  hence	  share	  redundancy	  in	  providing	  homeostatic	  signals	  to	  Treg	  in	  the	  
spleen	  that	  are	  non-­‐essential,	  but	  required	  for	  optimal	  Treg	  survival.	  As	  lost	  numbers	  of	  Treg	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in	  these	  knockout	  models	  included,	  but	  was	  not	  restricted	  to,	  ICOS/44+	  cells,	  memory	  Treg	  
and	  conventional	  memory	  cells	  cannot	  share	  signaling	  requirements	  for	  survival.	  	  
	   Interestingly,	  LNs	  from	  OX40	  and	  DKO	  mice	  were	  consistently	  enlarged,	  and	  
contained	  reduced	  proportions,	  but	  normal	  numbers,	  of	  Treg,	  thanks	  to	  the	  expansion	  of	  
conventional	  CD4s.	  This	  may	  suggest	  expansion	  in	  response	  to	  either	  infection	  or	  recognition	  
of	  self-­‐antigen,	  although	  this	  cannot	  lead	  to	  pathogenicity	  in	  OX40-­‐/-­‐	  mice,	  as	  T-­‐cells	  lack	  the	  
capacity	  to	  produce	  inflammatory	  cytokines63.	  T-­‐cell	  expansion	  could	  be	  diagnostic	  of	  
defective	  Treg	  suppression,	  and	  hence	  it	  would	  be	  interesting	  to	  find	  the	  role	  played	  by	  
OX40	  in	  their	  generation	  and	  homeostasis	  -­‐	  whether	  deletion	  limits	  the	  TCR	  repertoire	  or	  
suppressive	  capacity	  of	  those	  Treg	  that	  are	  produced	  –	  and	  indeed	  where	  OX40L	  is	  
expressed	  in	  the	  thymus.	  The	  ability	  of	  OX40-­‐/-­‐	  Treg	  to	  regulate	  can	  easily	  be	  assessed	  by	  co-­‐
transfer	  with	  total	  Foxp3-­‐/-­‐	  lymphocytes	  into	  a	  mouse	  lacking	  T-­‐cells	  (e.g.	  RAG-­‐/-­‐)	  –	  failure	  to	  
regulate	  will	  present	  as	  massive	  auto-­‐immunity,	  detectable	  by	  effector	  cell	  expression	  of	  
IFNγ	  and	  tissue	  invasion,	  and	  the	  production	  of	  auto-­‐antibodies45.	  
	  
5.3:	  Conclusion	  
	   Although	  we	  have	  shed	  some	  light	  on	  the	  factors	  required	  for	  the	  development	  of	  
memory–phenotype	  Treg,	  and	  indeed	  nTreg	  as	  a	  whole,	  further	  studies	  are	  required	  to	  
elucidate	  the	  origin	  of	  these	  cells	  –	  whether	  they	  assume	  their	  activated	  phenotype	  solely	  
after	  peripheral	  antigen	  encounter,	  or	  whether	  they	  are	  a	  heterogenous	  population,	  some	  of	  
which	  are	  phenotypically	  distinct	  from	  thymic	  generation.	  Although	  some	  studies	  have	  
attributed	  high	  suppressor	  function,	  proliferative	  capability	  and	  resistance	  to	  apoptosis	  
specifically	  to	  ICOS+	  Treg36,37,	  we	  have	  found	  the	  distribution	  and	  phenotype	  of	  ICOS/44	  co-­‐
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expressing	  populations	  to	  vary.	  Hence	  we	  would	  be	  interested	  to	  divide	  ICOS+	  Treg	  into	  
intermediate	  and	  high	  sub-­‐populations,	  and	  re-­‐evaluate	  these	  capabilities,	  together	  with	  
assessing	  the	  expression	  of	  suppressive	  cytokines	  (TGFβ,	  IL-­‐10)	  and	  surface	  molecules	  (CTLA-­‐
4)	  upon	  in	  vitro	  activation.	  
	   Another	  preliminary	  study	  on	  Treg	  populations	  in	  two	  Aire-­‐/-­‐	  mice	  also	  yielded	  an	  
interesting	  result	  worth	  pursuing.	  We	  confirmed	  previous	  findings	  that	  Aire-­‐/-­‐	  Treg	  
generation	  is	  inhibited17,	  as	  thymic	  Treg	  numbers	  were	  ~50%	  of	  wildtype,	  although	  
precursor	  formation	  is	  unaffected17.	  ICOS/44	  expression	  was	  normal,	  suggesting	  that	  
selection	  on	  TSAs	  and	  medullary	  DCs	  does	  not	  differentiate	  ICOS+	  cells,	  with	  TSA	  selection	  
redundant	  in	  generation	  of	  CD25+	  precursors.	  Aire-­‐/-­‐	  mice	  are	  known	  to	  be	  prone	  to	  tissue-­‐
specific	  auto-­‐immunity,	  which	  we	  confirmed	  through	  autoantibody	  screens,	  revealing	  
reactivity	  against	  gut	  and	  glomerular	  tissue	  (not	  shown).	  In	  one	  of	  these	  mice	  we	  observed	  
enlargement	  of	  the	  iLNs,	  accompanied	  by	  an	  expansion	  of	  Treg,	  specifically	  ICOS/44hi	  cells.	  It	  
would	  hence	  be	  of	  interest	  to	  observe	  and	  compare	  the	  roles	  of	  ICOS/44neg/int/hi	  Treg	  
populations	  in	  controlling	  autoimmune	  responses,	  particularly	  whether	  ICOS/44hi	  cells	  take	  a	  
central	  role,	  which	  could	  be	  achieved	  using	  the	  clever	  inducible	  skin-­‐inflammation	  model	  of	  
Rosenblum	  et	  al33.	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